Polymarket traders are still pricing October as the most likely month for Anthropic's stock market listing, even after reports that the roadshow has slipped later than first expected.
Working from the platform's cumulative contracts, the implied probability of a listing occurring specifically within October stands at 63%, calculated from the 64% chance priced in for a listing by 31 October against a 1% chance priced in for 30 September.
That compares with an implied 21% probability for November and just 6% for December, based on the gap between the 85% priced in for 30 November, the 64% for 31 October, and the 91% for 31 December.
The numbers have moved, however.
Two weeks ago, the 31 October contract alone was trading above 80%, before slipping back as reports emerged that Anthropic's formal roadshow, the period in which executives pitch the company to institutional investors, would not begin before mid-October.
That timeline was reportedly pushed back partly by ongoing negotiations over a $15 billion revolving credit facility, alongside a delay to the public prospectus filing.
Anthropic's underwriters, Goldman Sachs, JPMorgan Chase and Morgan Stanley (NYSE:MS), are said to be targeting a listing in the days before the 3 November US midterm elections, according to market commentary attached to the Polymarket contract.
The company confidentially filed its registration statement with the US Securities and Exchange Commission on 1 June, and has retained the law firm Wilson Sonsini for the legal groundwork.
Its last private funding round, a $65 billion raise in May, valued Anthropic at $965 billion, with reports putting its annualised revenue run rate at $65 billion by the end of July.
A separate Polymarket contract on Anthropic's eventual market capitalisation shows traders split between a valuation of $1.75 trillion to $2 trillion, on 26%, and $2 trillion to $2.25 trillion, on 22%.
Anthropic has not confirmed a date and has declined to comment on the reported timetable.
No Investment Advice
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
Versant Media's (VSNT.O) MS Now cable network is rolling out a membership program featuring live Q&A sessions, allowing users to directly chat with its anchors and reporters, as the company leans on direct-to-consumer offerings to boost engagement.
The membership will be available for purchase on Apple and Google app stores and the MS Now website, the company said, adding that it would roll it out to more platforms and devices in the future.
Members can ask MS Now reporters questions through live chats with hosts including Rachel Maddow and Morning Joe's Joe Scarborough at noon, as well as send in questions for newsroom reporters later in the day.
The move is the latest in Versant's push for growth as a standalone company after the CNBC owner's spin-off from Comcast (CMCSA.O). The company has been focused on driving digital platform growth as its legacy linear TV business contracts.
Key Takeaways GS and MS face greater sensitivity as IB and institutional trading remain key earnings drivers.Strength in M&A, equity issuance and trading could partly offset weakness in debt capital markets.Loan and deposit growth could cushion JPM, BAC and C against softer capital markets revenues. The U.S. banking industry entered the third quarter of 2026 with a supportive operating backdrop, characterized by healthy loan and deposit growth, resilient trading activity and improving dealmaking conditions. However, recent capital markets indicators suggest that the quarter may not be as strong as initially anticipated, particularly for banks with greater exposure to investment banking (IB) and trading.
According to a Yahoo Finance article citing Evercore’s August Capital Markets Monthly report, quarter-to-date industry indicators are tracking below expectations, suggesting that consensus estimates for third-quarter investment banking (IB) and trading revenues may be somewhat elevated. This could have varying implications for JPMorgan (JPM - Free Report) , Bank of America (BAC - Free Report) , Citigroup (C - Free Report) , Goldman Sachs (GS - Free Report) and Morgan Stanley (MS - Free Report) , given the differing contributions of capital markets businesses to their overall revenues.
Banks with greater dependence on advisory, underwriting and institutional trading are likely to be more sensitive to any shortfall, while diversified institutions could receive greater support from lending, payments, wealth management and other recurring revenue streams. Consequently, third-quarter performance could vary meaningfully across the major U.S. banks despite a generally favorable industry backdrop.
Investment Banking & Trading Trends Remain MixedCapital markets trends have been mixed so far in the third quarter. IB volumes declined 6% year over year in July due to an 18% drop in debt capital markets and syndicated lending. However, strength in other areas remained encouraging, with equity capital markets volumes surging 119% and merger and acquisition (M&A) activity rising 11%.
Trading indicators have been relatively stronger. Within fixed income, currencies and commodities (FICC), foreign exchange trading volumes increased 17% year over year, commodities rose 17%, credit gained 10% and rates activity increased 2%. In equities, Chicago Board Options Exchange (CBOE) volumes declined 4%, but retail trading activity jumped 43%, options volumes increased 14% and average margin balances rose 32%.
Overall, strength in M&A, equity issuance and client trading activity should provide support to capital markets revenues. Nevertheless, weakness in debt issuance and elevated Street expectations could cap the upside. Hence, even solid year-over-year growth in IB and trading revenues may not be enough for some banks to meet consensus estimates.
How JPM, BAC, C, GS & MS Stack UpAmong the five banks, Goldman Sachs and Morgan Stanley appear the most sensitive to weaker-than-expected capital markets conditions because IB and institutional trading remain key contributors to their earnings.
Goldman Sachs stands to benefit considerably from continued strength in M&A and equity underwriting, supported by its strong advisory franchise. Still, weakness in debt capital markets could offset some of those gains and moderate the pace of investment banking revenue growth.
Morgan Stanley faces similar exposure. However, its sizeable Wealth Management franchise provides a more stable revenue base that could help cushion any softness in investment banking or trading.
JPMorgan also has substantial exposure to investment banking and markets, making softer capital markets trends relevant to its third-quarter performance. Yet its highly diversified business mix, spanning consumer and commercial banking, payments and asset management, reduces its dependence on any single revenue source. This should provide JPM with a stronger buffer if underwriting or trading revenues fall short of expectations.
Bank of America and Citigroup could see a more balanced impact. Both operate sizeable investment banking and markets businesses, but their results are also driven substantially by traditional banking and recurring fee revenues. BAC’s large consumer banking and wealth-management franchises should provide an important cushion against weaker capital markets fees. Citigroup likewise benefits from a broader earnings mix that includes Services, Wealth and U.S. Personal Banking.
Balance-sheet trends could offer additional support. Evercore noted that average loan and deposit balances were each up 6% year over year. If this momentum continues, stronger balance-sheet growth could support net interest income and help offset capital markets softness, particularly at JPM, BAC and C.
What Investors Should WatchThe key takeaway is that third-quarter results across the major banks could diverge more sharply than headline industry trends imply.
Continued strength in M&A, equity underwriting and selected trading businesses could partly offset weakness in debt capital markets. At the same time, healthy loan and deposit growth could provide an important earnings cushion for banks with more diversified business models.
Investors should therefore look beyond headline IB and trading revenues and focus on the composition of results. Management commentary on deal pipelines, client activity, trading conditions and the durability of loan and deposit growth will also be important in assessing earnings momentum heading into the final quarter of the year.
Overall, the fundamental backdrop for the U.S. banking industry remains constructive. However, softer-than-expected capital markets indicators raise the possibility of a more uneven third-quarter earnings season, with GS and MS facing greater sensitivity to capital-markets trends and diversified players such as JPM, BAC and C benefiting from broader sources of earnings support.
California State Teachers Retirement System lifted its holdings in shares of Morgan Stanley (NYSE:MS – Free Report) by 20,805.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 374,314,131 shares of the financial services provider’s stock after purchasing an additional 372,523,624 shares during the period. California State Teachers Retirement System owned about 23.73% of Morgan Stanley worth $78,246,626,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Mitsubishi UFJ Financial Group Inc. bought a new stake in Morgan Stanley in the second quarter worth about $78,825,883,310. State Street Corp grew its position in shares of Morgan Stanley by 0.5% during the 4th quarter. State Street Corp now owns 103,854,751 shares of the financial services provider’s stock valued at $18,437,334,000 after acquiring an additional 539,544 shares during the period. Geode Capital Management LLC increased its stake in shares of Morgan Stanley by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 27,070,557 shares of the financial services provider’s stock worth $4,786,350,000 after purchasing an additional 534,708 shares during the last quarter. Fisher Asset Management LLC raised its holdings in shares of Morgan Stanley by 2.1% in the 4th quarter. Fisher Asset Management LLC now owns 25,018,335 shares of the financial services provider’s stock worth $4,441,505,000 after purchasing an additional 524,189 shares during the period. Finally, Bank of America Corp DE raised its holdings in shares of Morgan Stanley by 0.5% in the 1st quarter. Bank of America Corp DE now owns 16,326,676 shares of the financial services provider’s stock worth $2,686,881,000 after purchasing an additional 87,533 shares during the period. 84.19% of the stock is owned by hedge funds and other institutional investors.
Morgan Stanley Price Performance Shares of NYSE MS opened at $217.73 on Monday. The stock’s 50-day simple moving average is $215.70 and its two-hundred day simple moving average is $196.86. Morgan Stanley has a twelve month low of $146.29 and a twelve month high of $232.25. The firm has a market capitalization of $343.42 billion, a P/E ratio of 17.60, a P/E/G ratio of 1.54 and a beta of 1.21. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 3.65.
Morgan Stanley (NYSE:MS – Get Free Report) last issued its quarterly earnings data on Wednesday, July 15th. The financial services provider reported $3.46 EPS for the quarter, topping the consensus estimate of $2.89 by $0.57. The company had revenue of $21.35 billion during the quarter, compared to analyst estimates of $19.67 billion. Morgan Stanley had a return on equity of 19.31% and a net margin of 15.65%.Morgan Stanley’s revenue was up 27.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.13 earnings per share. As a group, equities analysts anticipate that Morgan Stanley will post 12.8 EPS for the current fiscal year. Morgan Stanley announced that its board has initiated a share repurchase program on Wednesday, June 24th that authorizes the company to buyback $20.00 billion in shares. This buyback authorization authorizes the financial services provider to purchase up to 5.6% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.
The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 31st were paid a $1.15 dividend. The ex-dividend date of this dividend was Friday, July 31st. This represents a $4.60 dividend on an annualized basis and a yield of 2.1%. This is a boost from Morgan Stanley’s previous quarterly dividend of $1.00. Morgan Stanley’s dividend payout ratio is presently 37.19%.
Wall Street Analyst Weigh In Several equities analysts have weighed in on the company. Royal Bank Of Canada reissued a “sector perform” rating and set a $243.00 price objective on shares of Morgan Stanley in a report on Monday, July 20th. The Goldman Sachs Group boosted their target price on Morgan Stanley from $211.00 to $233.00 and gave the company a “neutral” rating in a research note on Monday, July 6th. JPMorgan Chase & Co. upped their price target on Morgan Stanley from $187.00 to $195.00 and gave the company a “neutral” rating in a research report on Thursday, July 16th. Zacks Research raised Morgan Stanley from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. Finally, HSBC boosted their price objective on Morgan Stanley from $190.00 to $215.00 and gave the company a “hold” rating in a research note on Tuesday, July 21st. Three research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Morgan Stanley currently has a consensus rating of “Moderate Buy” and an average price target of $224.75.
Check Out Our Latest Stock Report on Morgan Stanley
Key Stories Impacting Morgan Stanley Here are the key news stories impacting Morgan Stanley this week:
Positive Sentiment: Potentially major Anthropic IPO role: Morgan Stanley and Goldman Sachs are reportedly close to receiving leading roles in Anthropic’s anticipated IPO, which could involve a valuation near $2 trillion. The deal would strengthen Morgan Stanley’s technology and equity-underwriting franchise and provide a potentially meaningful source of fees and future business. Anthropic is also reportedly arranging a $15 billion revolving credit facility, with Morgan Stanley leading the process. Anthropic close to awarding Morgan Stanley and Goldman top roles in $2tn IPO Positive Sentiment: Strong recent earnings backdrop: Morgan Stanley’s latest quarterly results significantly exceeded expectations, with revenue up 27.1% year over year and earnings per share of $3.46 versus a $2.89 consensus estimate. The performance supports investor confidence in the firm’s trading, investment-banking and wealth-management businesses. Neutral Sentiment: Ongoing conference and client activity: Morgan Stanley is hosting its 24th Annual Global Healthcare Conference, while companies including Tempus, Attovia Therapeutics, Eaton and Southwest Airlines are scheduled to present. These events reinforce the firm’s role in institutional research and client engagement but are unlikely to materially affect near-term financial results. Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Negative Sentiment: Copyright dispute with X: Morgan Stanley has filed complaints against at least 16 X posts that allegedly shared copyrighted research and temporarily locked a prominent strategist’s account. The action may protect valuable intellectual property, but it also creates reputational and legal uncertainty and could disrupt the firm’s visibility on a major platform used by investors. Morgan Stanley Hands Elon Musk a New X Headache Morgan Stanley Profile (Free Report)
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Read More Five stocks we like better than Morgan Stanley AI Token Costs Are Changing the Hardware vs. Software Debate 3 ETFs That Could Move as Rate Expectations Shift 3 Stocks With September Catalysts Investors Shouldn’t Ignore Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
Morgan Stanley (MS - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this investment bank have returned +0.6%, compared to the Zacks S&P 500 composite's -0.1% change. During this period, the Zacks Financial - Investment Bank industry, which Morgan Stanley falls in, has gained 1.3%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, Morgan Stanley is expected to post earnings of $3.01 per share, indicating a change of +7.5% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.1% over the last 30 days.
The consensus earnings estimate of $12.8 for the current fiscal year indicates a year-over-year change of +25.4%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $13.08 indicates a change of +2.2% from what Morgan Stanley is expected to report a year ago. Over the past month, the estimate has changed +0.2%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Morgan Stanley is rated Zacks Rank #1 (Strong Buy).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Morgan Stanley, the consensus sales estimate for the current quarter of $19.88 billion indicates a year-over-year change of +9.1%. For the current and next fiscal years, $81.87 billion and $84.85 billion estimates indicate +15.9% and +3.6% changes, respectively.
Last Reported Results and Surprise HistoryMorgan Stanley reported revenues of $21.35 billion in the last reported quarter, representing a year-over-year change of +27.1%. EPS of $3.46 for the same period compares with $2.13 a year ago.
Compared to the Zacks Consensus Estimate of $19.6 billion, the reported revenues represent a surprise of +8.9%. The EPS surprise was +19.72%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Morgan Stanley is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Morgan Stanley. However, its Zacks Rank #1 does suggest that it may outperform the broader market in the near term.
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.
Headquartered in New York, Morgan Stanley (MS - Free Report) is a Finance stock that has seen a price change of 22.32% so far this year. Currently paying a dividend of $1.15 per share, the company has a dividend yield of 2.12%. In comparison, the Financial - Investment Bank industry's yield is 1.16%, while the S&P 500's yield is 1.36%.
Looking at dividend growth, the company's current annualized dividend of $4.60 is up 19.5% from last year. Over the last 5 years, Morgan Stanley has increased its dividend 4 times on a year-over-year basis for an average annual increase of 22.85%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Morgan Stanley's current payout ratio is 32%, meaning it paid out 32% of its trailing 12-month EPS as dividend.
Looking at this fiscal year, MS expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $12.79 per share, with earnings expected to increase 25.27% from the year ago period.
Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. It's important to keep in mind that not all companies provide a quarterly payout.
Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, MS presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #1 (Strong Buy).
Commitments run from $1.25 billion down to $750 million depending on rank Summary
Anthropic's new facility is six times last year's $2.5 billion line, following the pattern SpaceX set before listing.
Anthropic is close to finalizing a $15 billion revolving credit facility ahead of its planned IPO, with Morgan Stanley MS leading and Goldman Sachs GS, JPMorgan Chase JPM and Citigroup C in prominent roles. Those same four are leading the offering. Barclays and Wells Fargo are expected to take key positions on the loan.
Anthropic asked its most active lenders for roughly $1.25 billion each, the next tier for about $1 billion, and less active participants for around $750 million or below. In syndicated lending, larger commitments earn higher fees, and a higher ranking on the revolver typically signals a more active role in the listing to come.
The facility is six times the $2.5 billion five-year line Anthropic arranged last year. SpaceX (SPCX) ran a similar sequence, expanding its revolver to $5 billion in May from $1.5 billion, a month before an $86.2 billion debut. Anthropic is targeting a raise at least the size of SpaceX's.
Disclosures I am/we currently own positions in the stocks mentioned, and have NO plans to sell some or all of the positions in the stocks mentioned over the next 72 hours.
Anthropic is close to finalising an expansion of its revolving credit facility to $15 billion, according to people familiar with the matter, clearing a key hurdle before the AI company files publicly for its highly anticipated IPO.
Morgan Stanley (NYSE:MS) is leading the process, with Goldman Sachs, JPMorgan Chase and Citigroup also holding prominent roles on the facility. The same four lenders are reported to be leading the IPO itself.
Raise seen rivalling SpaceX
The Claude chatbot maker is seeking to raise as much as SpaceX or more in its initial public offering, according to people familiar with the preparations. Companies typically finalise a revolver of this kind before formally notifying banks of their roles in a listing — making the credit facility a signal of IPO timing as much as a financing event in its own right.
Wider banking syndicate
Barclays and Wells Fargo are also expected to take key roles on the loan, with Bank of America, Deutsche Bank, Royal Bank of Canada (TSX:RY) and UBS ranked high in the facility's lineup. Bank of Montreal, BNP Paribas, Crédit Agricole, Mizuho, Mitsubishi UFJ, Sumitomo Mitsui and Toronto-Dominion Bank (TSX:TD) round out the syndicate.
In syndicated loans, a bank's fee income generally scales with its commitment — meaning a higher ranking on the facility can also point to a more active role should the IPO proceed.
Above initial target
The facility would exceed the roughly $10 billion target reported last month. Anthropic had asked the most active lead banks to commit about $1.25 billion each, with the next tier encouraged to offer around $1 billion, and commitments falling to roughly $750 million or lower for less active participants, according to the earlier reporting.
Terms still in flux
Details of the loan could still change, the people said, speaking on condition of anonymity as the information isn't public. Representatives for Anthropic, JPMorgan, Barclays, Wells Fargo and UBS declined to comment; the other banks did not immediately respond to requests for comment.
Anthropic is close to finalising an expansion of its revolving credit facility to $15 billion, according to people familiar with the matter, clearing a key hurdle before the AI company files publicly for its highly anticipated IPO.
Morgan Stanley (NYSE:MS) is leading the process, with Goldman Sachs, JPMorgan Chase and Citigroup also holding prominent roles on the facility. The same four lenders are reported to be leading the IPO itself.
Raise seen rivalling SpaceX
The Claude chatbot maker is seeking to raise as much as SpaceX or more in its initial public offering, according to people familiar with the preparations. Companies typically finalise a revolver of this kind before formally notifying banks of their roles in a listing — making the credit facility a signal of IPO timing as much as a financing event in its own right.
Wider banking syndicate
Barclays and Wells Fargo are also expected to take key roles on the loan, with Bank of America, Deutsche Bank, Royal Bank of Canada (TSX:RY) and UBS ranked high in the facility's lineup. Bank of Montreal, BNP Paribas, Crédit Agricole, Mizuho, Mitsubishi UFJ, Sumitomo Mitsui and Toronto-Dominion Bank (TSX:TD) round out the syndicate.
In syndicated loans, a bank's fee income generally scales with its commitment — meaning a higher ranking on the facility can also point to a more active role should the IPO proceed.
Above initial target
The facility would exceed the roughly $10 billion target reported last month. Anthropic had asked the most active lead banks to commit about $1.25 billion each, with the next tier encouraged to offer around $1 billion, and commitments falling to roughly $750 million or lower for less active participants, according to the earlier reporting.
Terms still in flux
Details of the loan could still change, the people said, speaking on condition of anonymity as the information isn't public. Representatives for Anthropic, JPMorgan, Barclays, Wells Fargo and UBS declined to comment; the other banks did not immediately respond to requests for comment.
4:25pm: Rate fears fade Wall Street ended Thursday sharply higher, with the Dow and S&P 500 posting their best daily performances in about a month as easing fears of a Federal Reserve rate hike lifted sentiment.
The Dow Jones Industrial Average gained 624 points, or 1.2%, to 53,686, while the S&P 500 climbed 1.1% to 7,748 and the Nasdaq jumped 1.4% to 26,584.
Lower Treasury yields and comments from Fed Governor Christopher Waller helped calm concerns that rates could move higher this month, giving investors more room to rotate back into growth and technology stocks.
Tech stocks remained a key source of volatility, with high-valuation semiconductor and software names swinging as investors weighed growth expectations against mixed earnings results. Still, gains across major technology companies helped the Nasdaq lead the broader market higher.
Attention now turns to the next batch of corporate results, with Lululemon, Zscaler and DocuSign due to report after the bell.
3:40pm: Small cap wrap Tiziana Life Sciences Ltd (NASDAQ:TLSA) received a Buy rating and $7 price target from BTIG, which highlighted its nasal anti-CD3 antibody foralumab and its potential to reduce inflammation associated with neurodegenerative diseases. Ocean Power Technologies Inc (NYSE-A:OPTT) is implementing Palantir Foundry to improve visibility across its autonomous maritime systems operations, including manufacturing, supply chain management, deployment, fleet operations, maintenance and customer support. Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) said TotalEnergies has completed its acquisition of a 40% operated interest in Namibia’s PEL 83, where Sintana holds an indirect stake in the Mopane discoveries. American Resources Corp (NASDAQ:AREC) has joined the Critical Minerals Institute as its first Platinum member, gaining access to a global executive network and market, pricing, intelligence and supply chain data through the Critical Minerals Platform. Thistle Resources (TSX-V:TRCG, OTC:TRCGF) has launched a 3,000-metre Phase 3 drill program at its Middle River Gold Project to further test the MRG Upper Zone following two earlier programs that delivered strong gold intersections. BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) plans to dual-list its ordinary shares on the Tel Aviv Stock Exchange, with trading expected to begin on September 8, 2026, giving Israeli investors access to the Nasdaq-listed company. Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) reported August sales volumes of 3,124 barrels of oil equivalent per day, broadly in line with July, while its 183-D1 well in Brazil flowed at an average 1.12 MMcfpd during an 11-day test. 2:20pm: Market movers Broadcom Inc (NASDAQ:AVGO, XETRA:1YD) shares fell 3.3% despite the company raising its fiscal 2027 AI revenue outlook to $115 billion and projecting $230 billion in AI revenue for fiscal 2028. Snowflake Inc (NYSE:SNOW) shares jumped more than 20% after a blowout second-quarter report showed accelerating product revenue growth and strong enterprise adoption of its AI offerings, prompting Bank of America to raise its price target to $470. Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) said TotalEnergies has completed its acquisition of a 40% operated interest in Namibia’s PEL 83, where Sintana holds an indirect stake in the Mopane discoveries. Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) shares climbed more than 4% after the company unveiled its Muse Spark 1.3 AI model, which it said now matches offerings from Anthropic and OpenAI. Campbell Soup Company (NYSE:CPB) reported a 37% drop in adjusted fourth-quarter earnings and an 8% decline in revenue while cutting its quarterly dividend by 36% to accelerate debt reduction and strengthen its balance sheet. Ocean Power Technologies Inc (NYSE-A:OPTT) is implementing Palantir Foundry to improve visibility across its autonomous maritime systems operations, from manufacturing and supply chain management to fleet deployment, maintenance and customer support. Victoria's Secret & Co. (NYSE:VSCO) shares fell more than 12% after its third-quarter profit outlook came in below expectations despite a second-quarter earnings beat and higher full-year guidance. ChargePoint shares surged 53% after the EV charging company beat quarterly revenue expectations and reported a smaller-than-expected loss, with revenue rising 18% to $116.1 million. Hewlett Packard Enterprise Co (NYSE:HPE, XETRA:2HP) beat fiscal third-quarter expectations and raised its full-year guidance on broad-based demand, record orders and backlog as it prepares for increased spending on agentic AI. 1:15pm: Snowflake's blowout quarter Snowflake Inc (NYSE:SNOW) (Snowflake Inc (NYSE:SNOW)) shares jumped more than 20% on Thursday following a blowout second-quarter earnings report, driven by accelerating product revenue growth and surging enterprise adoption of its AI offerings.
Bank of America raised its price objective on the stock to $470 from $395, citing accelerating product revenue growth and reiterating a Buy rating.
BofA said newer customer cohorts are ramping toward purchased capacity faster than prior cohorts, with recent cohorts reaching 80% of purchased consumption materially sooner.
The bank pointed to faster deployments, AI-enabled migrations, and growing adoption of Snowflake's CoCo and CoWork offerings as drivers of the stronger trends.
11:30am: Dovish Fed tone supports stocks, A more dovish tone from Federal Reserve officials is helping keep equities and gold supported while putting further pressure on the US dollar, according to Chris Beauchamp, chief market analyst at IG.
Beauchamp said Fed Governor Christopher Waller was the latest policymaker to strike a relatively dovish tone, following recent comments from Fed Chair Kevin Warsh. Waller indicated that he could support keeping interest rates unchanged this month if upcoming inflation data confirms that price pressures are easing, helping lift stocks while Treasury yields and the dollar moved lower.
"If the idea is to keep investors guessing, then the Fed is succeeding, but so far the data appears to lean towards the dovish argument. But as was the case 24 hours ago, everything rides on tomorrow’s payrolls and then next Friday’s inflation readings," Beauchamp commented. "Equities aren’t out of the woods yet.”
10:00am: AI optimism returns Wall Street is starting the session on firmer footing, with all three major indexes moving higher as investors weigh Middle East tensions against a fresh batch of economic and corporate signals.
The Dow Jones Industrial Average was up 0.7% at 53,445, while the S&P 500 gained 0.5% to 7,708 and the Nasdaq Composite climbed 0.7% to 26,402. Falling Treasury yields are also helping sentiment, while strong corporate earnings and renewed optimism around artificial intelligence have given stocks some support after a shaky start to the week.
The latest economic data offered a mixed picture. The August ISM services PMI came in at 55.4, comfortably above the 54.1 estimate, with new orders jumping to 60.9 from expectations of 56. However, the employment component slipped to 47.8, while prices paid rose to 72.6, suggesting that inflation pressures remain a concern.
Meanwhile, the US trade deficit widened 24.4% month over month to $88.6 billion in July, its largest gap since early 2025, as imports increased 2.8% while exports fell 2.1%.
There was also a dovish note from Fed Governor Chris Waller, who said he would support keeping interest rates at 3.50%-3.75% this month if upcoming inflation data continues to show progress toward the Fed’s 2% target. Still, Waller warned that a renewed deterioration in inflation could warrant a rate hike.
On the corporate side, Robinhood is surging after Morgan Stanley (NYSE:MS) upgraded the stock to Overweight with a $150 price target, while Scotiabank (TSX:BNS) and Piper Sandler also raised their targets.
Victoria’s Secret is heading in the opposite direction, falling 13.7% after its earnings beat was offset by a small revenue miss and lighter third-quarter operating income guidance.
Ahead of the bell US stock futures are pointing to a relatively quiet open Thursday as investors look for some stability after a rough start to September and Wall Street snapped its recent losing streak.
Futures on the Dow Jones Industrial Average were up around 0.2%, while S&P 500 futures were little changed. Nasdaq-100 futures edged slightly lower, suggesting technology stocks could open on a softer note.
Broadcom will be in focus after its shares trimmed some of their after-hours losses. The stock initially tumbled as much as 4% following its latest results, keeping the spotlight on the semiconductor and AI trade.
Snowflake, meanwhile, is providing a brighter spot for the tech sector, with shares surging after the company reported earnings that benefited from strong demand for artificial intelligence.
There will be more earnings to digest after the close, with DocuSign, Zscaler and Lululemon set to report.
The economic calendar could also keep investors busy. Weekly jobless claims are due at 8:30 am ET, followed by the Institute for Supply Management’s August services PMI. Federal Reserve Governor Christopher Waller is also scheduled to speak this morning, with markets watching closely for clues about whether he thinks the central bank should raise interest rates this month.
Bond markets are offering stocks some relief, with Treasury yields easing Thursday after the 10-year yield climbed to a multi-year high on Wednesday.
Still, the pressure has not disappeared. As Kathleen Brooks, research director at XTB, noted, inflation concerns have not gone away and another bond sell-off remains possible. “10-year US Treasury yields are still higher by 13bps this week,” Brooks said. “However, after a rough start to September, it could be time to take a breather.”
3:40pm: Small cap wrap Tiziana Life Sciences Ltd (NASDAQ:TLSA) received a Buy rating and $7 price target from BTIG, which highlighted its nasal anti-CD3 antibody foralumab and its potential to reduce inflammation associated with neurodegenerative diseases. Ocean Power Technologies Inc (NYSE-A:OPTT) is implementing Palantir Foundry to improve visibility across its autonomous maritime systems operations, including manufacturing, supply chain management, deployment, fleet operations, maintenance and customer support. Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) said TotalEnergies has completed its acquisition of a 40% operated interest in Namibia’s PEL 83, where Sintana holds an indirect stake in the Mopane discoveries. American Resources Corp (NASDAQ:AREC) has joined the Critical Minerals Institute as its first Platinum member, gaining access to a global executive network and market, pricing, intelligence and supply chain data through the Critical Minerals Platform. Thistle Resources (TSX-V:TRCG, OTC:TRCGF) has launched a 3,000-metre Phase 3 drill program at its Middle River Gold Project to further test the MRG Upper Zone following two earlier programs that delivered strong gold intersections. BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) plans to dual-list its ordinary shares on the Tel Aviv Stock Exchange, with trading expected to begin on September 8, 2026, giving Israeli investors access to the Nasdaq-listed company. Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) reported August sales volumes of 3,124 barrels of oil equivalent per day, broadly in line with July, while its 183-D1 well in Brazil flowed at an average 1.12 MMcfpd during an 11-day test. 2:20pm: Market movers Broadcom Inc (NASDAQ:AVGO, XETRA:1YD) shares fell 3.3% despite the company raising its fiscal 2027 AI revenue outlook to $115 billion and projecting $230 billion in AI revenue for fiscal 2028. Snowflake Inc (NYSE:SNOW) shares jumped more than 20% after a blowout second-quarter report showed accelerating product revenue growth and strong enterprise adoption of its AI offerings, prompting Bank of America to raise its price target to $470. Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) said TotalEnergies has completed its acquisition of a 40% operated interest in Namibia’s PEL 83, where Sintana holds an indirect stake in the Mopane discoveries. Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) shares climbed more than 4% after the company unveiled its Muse Spark 1.3 AI model, which it said now matches offerings from Anthropic and OpenAI. Campbell Soup Company (NYSE:CPB) reported a 37% drop in adjusted fourth-quarter earnings and an 8% decline in revenue while cutting its quarterly dividend by 36% to accelerate debt reduction and strengthen its balance sheet. Ocean Power Technologies Inc (NYSE-A:OPTT) is implementing Palantir Foundry to improve visibility across its autonomous maritime systems operations, from manufacturing and supply chain management to fleet deployment, maintenance and customer support. Victoria's Secret & Co. (NYSE:VSCO) shares fell more than 12% after its third-quarter profit outlook came in below expectations despite a second-quarter earnings beat and higher full-year guidance. ChargePoint shares surged 53% after the EV charging company beat quarterly revenue expectations and reported a smaller-than-expected loss, with revenue rising 18% to $116.1 million. Hewlett Packard Enterprise Co (NYSE:HPE, XETRA:2HP) beat fiscal third-quarter expectations and raised its full-year guidance on broad-based demand, record orders and backlog as it prepares for increased spending on agentic AI. 1:15pm: Snowflake's blowout quarter Snowflake Inc (NYSE:SNOW) (Snowflake Inc (NYSE:SNOW)) shares jumped more than 20% on Thursday following a blowout second-quarter earnings report, driven by accelerating product revenue growth and surging enterprise adoption of its AI offerings.
Bank of America raised its price objective on the stock to $470 from $395, citing accelerating product revenue growth and reiterating a Buy rating.
BofA said newer customer cohorts are ramping toward purchased capacity faster than prior cohorts, with recent cohorts reaching 80% of purchased consumption materially sooner.
The bank pointed to faster deployments, AI-enabled migrations, and growing adoption of Snowflake's CoCo and CoWork offerings as drivers of the stronger trends.
11:30am: Dovish Fed tone supports stocks, A more dovish tone from Federal Reserve officials is helping keep equities and gold supported while putting further pressure on the US dollar, according to Chris Beauchamp, chief market analyst at IG.
Beauchamp said Fed Governor Christopher Waller was the latest policymaker to strike a relatively dovish tone, following recent comments from Fed Chair Kevin Warsh. Waller indicated that he could support keeping interest rates unchanged this month if upcoming inflation data confirms that price pressures are easing, helping lift stocks while Treasury yields and the dollar moved lower.
"If the idea is to keep investors guessing, then the Fed is succeeding, but so far the data appears to lean towards the dovish argument. But as was the case 24 hours ago, everything rides on tomorrow’s payrolls and then next Friday’s inflation readings," Beauchamp commented. "Equities aren’t out of the woods yet.”
10:00am: AI optimism returns Wall Street is starting the session on firmer footing, with all three major indexes moving higher as investors weigh Middle East tensions against a fresh batch of economic and corporate signals.
The Dow Jones Industrial Average was up 0.7% at 53,445, while the S&P 500 gained 0.5% to 7,708 and the Nasdaq Composite climbed 0.7% to 26,402. Falling Treasury yields are also helping sentiment, while strong corporate earnings and renewed optimism around artificial intelligence have given stocks some support after a shaky start to the week.
The latest economic data offered a mixed picture. The August ISM services PMI came in at 55.4, comfortably above the 54.1 estimate, with new orders jumping to 60.9 from expectations of 56. However, the employment component slipped to 47.8, while prices paid rose to 72.6, suggesting that inflation pressures remain a concern.
Meanwhile, the US trade deficit widened 24.4% month over month to $88.6 billion in July, its largest gap since early 2025, as imports increased 2.8% while exports fell 2.1%.
There was also a dovish note from Fed Governor Chris Waller, who said he would support keeping interest rates at 3.50%-3.75% this month if upcoming inflation data continues to show progress toward the Fed’s 2% target. Still, Waller warned that a renewed deterioration in inflation could warrant a rate hike.
On the corporate side, Robinhood is surging after Morgan Stanley (NYSE:MS) upgraded the stock to Overweight with a $150 price target, while Scotiabank (TSX:BNS) and Piper Sandler also raised their targets.
Victoria’s Secret is heading in the opposite direction, falling 13.7% after its earnings beat was offset by a small revenue miss and lighter third-quarter operating income guidance.
Ahead of the bell US stock futures are pointing to a relatively quiet open Thursday as investors look for some stability after a rough start to September and Wall Street snapped its recent losing streak.
Futures on the Dow Jones Industrial Average were up around 0.2%, while S&P 500 futures were little changed. Nasdaq-100 futures edged slightly lower, suggesting technology stocks could open on a softer note.
Broadcom will be in focus after its shares trimmed some of their after-hours losses. The stock initially tumbled as much as 4% following its latest results, keeping the spotlight on the semiconductor and AI trade.
Snowflake, meanwhile, is providing a brighter spot for the tech sector, with shares surging after the company reported earnings that benefited from strong demand for artificial intelligence.
There will be more earnings to digest after the close, with DocuSign, Zscaler and Lululemon set to report.
The economic calendar could also keep investors busy. Weekly jobless claims are due at 8:30 am ET, followed by the Institute for Supply Management’s August services PMI. Federal Reserve Governor Christopher Waller is also scheduled to speak this morning, with markets watching closely for clues about whether he thinks the central bank should raise interest rates this month.
Bond markets are offering stocks some relief, with Treasury yields easing Thursday after the 10-year yield climbed to a multi-year high on Wednesday.
Still, the pressure has not disappeared. As Kathleen Brooks, research director at XTB, noted, inflation concerns have not gone away and another bond sell-off remains possible. “10-year US Treasury yields are still higher by 13bps this week,” Brooks said. “However, after a rough start to September, it could be time to take a breather.”
NEW YORK--(BUSINESS WIRE)--E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, which indicates whether clients were net buyers or sellers in each of the 11 core stock market sectors defined by the Global Industry Classification Standard (GICS). These figures, which encompass activity in all US-traded stocks (including OTC) and ADRs, reflect purchases and sales of the individual stocks in each sector, as well as dividend investments and options exercises a.
Morgan Stanley (MS - Free Report) ended the recent trading session at $211.04, demonstrating a -1.07% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.71%. Elsewhere, the Dow saw a downswing of 0.79%, while the tech-heavy Nasdaq depreciated by 1.03%.
Coming into today, shares of the investment bank had gained 0.99% in the past month. In that same time, the Finance sector gained 0.84%, while the S&P 500 gained 2.72%.
The investment community will be paying close attention to the earnings performance of Morgan Stanley in its upcoming release. The company is expected to report EPS of $3.01, up 7.5% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $19.88 billion, up 9.07% from the prior-year quarter.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $12.79 per share and a revenue of $81.87 billion, indicating changes of +25.27% and +15.89%, respectively, from the former year.
Investors might also notice recent changes to analyst estimates for Morgan Stanley. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.01% increase. Morgan Stanley presently features a Zacks Rank of #1 (Strong Buy).
Looking at its valuation, Morgan Stanley is holding a Forward P/E ratio of 16.68. For comparison, its industry has an average Forward P/E of 14.76, which means Morgan Stanley is trading at a premium to the group.
It's also important to note that MS currently trades at a PEG ratio of 1.51. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The average PEG ratio for the Financial - Investment Bank industry stood at 1.02 at the close of the market yesterday.
The Financial - Investment Bank industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 32, finds itself in the top 14% echelons of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Morgan Stanley has lapped every major bank rival in 2026, but a rate spike just rattled the stock and the one price level that would confirm the bull case remains stubbornly out of reach.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A global bond selloff pushed the 10-year Treasury yield to 4.79% this afternoon, above its prior 52-week high of 4.75% set on July 31. Rising long rates typically help banks, yet the money-center group is soft, and so is the sector fund.
Notably, the Financial Select Sector SPDR ETF (NYSEARCA:XLF) was is 5% year to date (YTD) to $57.31, while the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 12%. This year so far, Morgan Stanley (NYSE:MS | MS Price Prediction) stock is beating both of those funds.
Morgan Stanley stock was up 19% year to date through Monday’s close, leading every money-center peer this year on the strength of wealth management fees and capital markets activity. Shares are down 0.6% to $212.03 this afternoon as the rate spike tips risk sentiment negative. Breaking $250 requires Morgan Stanley to clear a 52-week high it hasn’t touched in a year, and analyst targets have to move higher.
Ranking the Big Six Banks Five of the six largest U.S. banks beat XLF this year, and the fund’s lag reflects its broader mix of insurers, exchanges, and payment networks diluting money-center strength. Morgan Stanley led the group by a clear margin, while Wells Fargo’s more balance-sheet-oriented mix has left it below where it started 2026. The separation was earned in the earnings line.
Bank Ticker YTD 2026 Morgan Stanley MS +19% Goldman Sachs (NYSE:GS) GS +14% Bank of America (NYSE:BAC) BAC +13% Citigroup (NYSE:C) C +13% JPMorgan Chase (NYSE:JPM) JPM +10% Wells Fargo (NYSE:WFC) WFC -7% Morgan Stanley’s mix is what set the firm apart from the pack. Its year-over-year (YoY) earnings growth reached 62.4%, classed as strong earnings acceleration, and its beta of 1.209 sits above the money-center average, which cuts both ways. The 2026 story combines that earnings acceleration with a rate environment that rewarded fee-based and capital markets revenue over pure spread income.
Q2 2026 anchored the year for Morgan Stanley. The firm posted record revenue of $21.35 billion and EPS of $3.46, a fifth consecutive beat. Equity trading revenue climbed 69% to $6.30 billion, investment banking rose 58% to $2.44 billion, and total client assets across wealth and investment management reached the $10 trillion milestone.
What It Takes to Reach $250 Morgan Stanley stock trades at $212.03, and its 52-week high is $230.98, so the first step is clearing a level Morgan Stanley shares haven’t reached in a year. The average analyst price target is $236.62, which sits below $250. Ratings break down as 2 Strong Buy, 9 Buy, 13 Hold, 1 Sell, and no Strong Sell.
Morgan Stanley’s forward EPS is $13.42, and the implied P/E ratio comes to 17x. That’s a reasonable multiple for a firm producing record wealth management fees and capital markets revenue, but it doesn’t leave much room for multiple expansion without stronger earnings revisions.
24/7 Wall St.’s price model puts Morgan Stanley’s base case at $248.27, implying 17.2% upside, with an optimistic case of $258.86 and a conservative case of $212.41. So $250 sits just above the base case and inside the optimistic case, marking it as an achievable bull-case level. That’s a materially different answer from stocks whose targets sit below their price.
Rising Rates Complicate the Setup The 10-year Treasury yield at 4.79% sits above its prior one-year peak, and the move up in long rates has been sharp enough to unsettle risk assets even where it ought to help earnings. Higher long rates conventionally support bank net interest income, yet Morgan Stanley shares and XLF are both lower. A rate spike large enough to trigger risk-off can outweigh the margin benefit in a single session.
The yield curve stayed positive, with the 10-year minus 2-year spread at 0.41% at the latest read, a supportive backdrop for bank earnings over time. Morgan Stanley’s Q2 wealth-management net interest income rose to $2.3 billion, helped by higher sweep deposits and lending growth. The tension is between what today’s move does to trading positioning and what tomorrow’s curve does to lending economics.
What to Watch Two things have to happen for $250 to come into view. Morgan Stanley stock has to clear $230 with heavy trading volume, and analyst targets have to move up toward the 24/7 Wall St. base case, which in practice depends on capital markets activity holding through year-end. Traders can watch for signs that IPO and M&A pipelines convert to booked revenue in Q3 2026.
Capital return also supports the case, with a reauthorized $20 billion repurchase program starting Q3 and the quarterly dividend raised to $1.15. Given Morgan Stanley’s higher beta and its dependence on markets activity, investors should size their positions with room for the volatility that comes with a fee- and capital-markets-heavy mix. Both the base case and the bull case rely on those revenue lines holding.
Contact [email protected] for any questions or corrections.
Novartis NVS has seen a significant increase in its stock price following the positive outcomes of remibrutinib in the Phase III REMODEL trials. The drug demonstrated a notable reduction in annualized relapse rates compared to teriflunomide in patients with relapsing multiple sclerosis (MS). Additionally, remibrutinib showed superiority across all key secondary endpoints in both studies, including the reduction of inflammatory MRI lesions.
Both REMODEL-1 and REMODEL-2 trials were randomized, double-blind studies involving around 2,000 adults with relapsing MS. The success of these two independent trials strengthens regulatory evidence compared to relying on a single trial or pooled data. Remibrutinib effectively reduced inflammatory brain lesions, supporting the relapse rate findings. However, the three-month confirmed disability-progression endpoint did not achieve statistical significance, and the six-month result was only nominally significant, indicating that further evidence is needed to confirm its efficacy in slowing disability. NVS reported that remibrutinib was well tolerated, with no liver safety concerns and no cases meeting Hy’s Law criteria, which is crucial given the liver-toxicity issues associated with the BTK-inhibitor class. However, comprehensive data on infections, laboratory results, adverse events, and treatment discontinuations are still pending. Remibrutinib is currently approved as Rhapsido for chronic spontaneous urticaria, and its development program includes over 4,500 participants, establishing a solid safety profile. Its future in MS treatment will depend on its efficacy and convenience compared to anti-CD20 therapies and other emerging BTK inhibitors. Full results from the trials are set to be presented at MSToronto 2026 from October 21-23, followed by an investor call. Novartis is also planning to pursue global regulatory approval. As of now, the U.S.-listed ADRs for NVS are trading at $160.43, above their 50- and 200-day moving averages, but below the 52-week high of $170.46.The key takeaway is that remibrutinib has successfully navigated a significant clinical hurdle with two positive Phase III trials, strong secondary endpoint support, and a favorable safety profile. This combination enhances the likelihood of regulatory approval and positions NVS to offer a potentially distinctive oral therapy for MS. However, investors are still awaiting crucial data on relapse rates, treatment effects, MRI lesion counts, and safety profiles to accurately assess its competitiveness against established high-efficacy treatments. The upcoming MSToronto presentation will be critical in determining whether remibrutinib meets the expectations of its pivotal program or proves to be a transformative option in the MS treatment landscape.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.
KRE bundles roughly 140 regional banks into one tidy package, but that diversification comes at a quiet cost to dividend growth and total return that most income investors never stop to measure.
The SPDR S&P Regional Banking ETF (NYSEARCA:KRE) is the default way retail investors bet on America’s regional banks. KRE’s equal-weighted structure spreads roughly $4.7 billion in assets across community and mid-size lenders, giving holders a diversified line into Main Street lending, deposit franchises, and the eventual payoff from steeper yield curves. That is a defensible thesis. But if the reason you own KRE is dividend income backed by durable bank earnings, the ETF’s payout profile and total-return record look weaker once you place it next to a short list of individual bank stocks that have quietly done the heavier lifting.
Why KRE Attracts Income Investors KRE distributes quarterly and has paid out $1.59949 per share over the trailing twelve months, with an annualized forward figure of $1.666924. At a recent price of $73.66, that pencils out to a forward yield in the low 2% range. The fund is also up 15.96% year to date and 16.14% over one year. The pitch writes itself: bank sector rebound, a real yield, and ~140 names of diversification.
Where the ETF Falls Short Equal weighting is the problem hiding in plain sight. KRE’s top positions include names like Amerant Bancorp, Ameris Bancorp, Atlantic Union Bankshares, and Bank OZK, each roughly 1% to 1.4% of the fund. That construction dilutes exposure to the highest-quality franchises and tilts the basket toward smaller banks with more commercial real estate concentration and thinner net interest margins. It shows in the returns: KRE has returned just 27.35% over five years and 123.16% over ten. The dividend itself is lumpy, with quarterly amounts ranging from roughly $0.36 to $0.42 in recent periods rather than growing on a steady schedule.
JPMorgan: The Compounder KRE Cannot Match JPMorgan Chase (NYSE:JPM | JPM Price Prediction) posted a Q2 2026 ROTCE of 23% on EPS of $7.70 and revenue of $57.35 billion, with a new $50 billion buyback authorized on July 1, 2026. The quarterly dividend has climbed from $1.00 in 2023 to $1.50 today, a 50% raise in three years that KRE has not come close to matching. JPM has returned 148.66% over five years and 589.08% over ten. If your goal is a growing dividend backed by a fortress balance sheet, JPMorgan does what the ETF advertises but better (we ranked ten long-streak dividend growers by valuation in a free Dividend Kings report for readers who want more names in this vein).
U.S. Bancorp: A Higher Current Yield With Room to Grow The income case is even more direct for U.S. Bancorp (NYSE:USB). Its $0.52 quarterly payout annualizes to $2.08, which at $61.62 works out to a yield above 3%, meaningfully higher than KRE’s forward payout. Q2 2026 delivered ROTCE of 18.7%, EPS growth of 22% YoY, and a 13 basis point NIM expansion to 2.79%. Management guided to 7% to 9% revenue growth for 2026 and telegraphed another ~4% dividend increase in Q3 2026. USB is up 33.45% over one year.
Morgan Stanley: Fee Income Instead of Rate Risk Morgan Stanley (NYSE:MS) trades the interest-rate sensitivity that hurts regional banks for wealth and investment banking fees. Q2 2026 brought record revenue of $21.35 billion, EPS of $3.46, and ROTCE of 26.6%, with Wealth Management adding $148 billion in net new assets. The dividend jumped to $1.15 per quarter in July, up from $0.35 in 2020. The stock has returned 782.37% over ten years against KRE’s 123%.
Tradeoffs You Are Accepting Swapping KRE for these three names concentrates you in money-center and super-regional franchises. You give up pure-play exposure to the ~140-name regional basket that would benefit most if smaller banks re-rate on falling short rates or M&A activity. You also take on single-stock risk: one legal settlement or trading loss hits harder than it would inside an index. In a taxable account, selling KRE could realize gains after this year’s 15.96% run, so consider redirecting new contributions rather than liquidating outright.
Making the Call If you own KRE for thematic regional-bank exposure, keep it. If you own it for income and total return from bank earnings, a roughly equal split across JPM, USB, and MS delivers a comparable or higher current yield, a demonstrably faster-growing dividend, and higher-quality earnings power. KRE works as a diversified sector vehicle, yet three specific stocks inside and adjacent to the sector have simply done the job better on income and total return.
Contact [email protected] for any questions or corrections.
NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management, through investment funds managed by Morgan Stanley Real Estate Investing (MSREI), announced today the acquisition of a Class A seniors housing portfolio located in the Orlando and Tampa metropolitan areas. The portfolio includes two communities comprising 300 independent living, assisted living and memory care units serving residents in Central Florida. AgeWell Senior Living, a Florida-based seniors housing operator, will continue.
Na Bloombergu se věnovali slovům nového předsedy americké centrální banky Kevina Warshe, která poukazovala na problém vzájemné závislosti trhů a Fedu. Tedy na trhy sledující signály z Fedu a na Fed sledující zase signály tržní. Andrew Slimmon z Morgan Stanley k tomu řekl svůj pohled na současné dění na trzích a pár úvah o tom, jak by na něj mohli investoři reagovat.
Warsh konkrétně hovořil o tom, že pokud se Fed s trhy sledují navzájem a zakládají na tom úvahy o dalším vývoji, může to vést k nepřipravenosti na nové události a příliš opožděné reakci. Slimmon to komentoval s tím, že Warsh už v minulosti nechtěl, aby Fed byl přehnaně komunikativní a svými signály „vedl trhy“. Jeho současná prohlášení se stále nesou v tomto duchu a podle experta tak Warsh zůstává konzistentní. Takový postup je „zdravý“ a Slimmona podle jeho slov těší.
Na trzích už podle experta dochází ke změnám, na ně totiž není třeba, aby Fed sazby skutečně zvyšoval. Stačí „hrozba jejich růstu“. Na akciích je tak jasný posun směrem od spekulativních akcií, protože těm prospívá prostředí klesajících sazeb. Bylo to zřejmé minulý rok poté, co Jay Powell v Jackson Hole mluvil o snižování sazeb. Nyní se ale podle Slimmona investoři obrací směrem k akciím a společnostem stabilnějším a větším, které by nebyly tak zranitelné, pokud by sazby šly skutečně výš. Pozitivní by to podle něj bylo i pro finanční tituly.
Ekonomika je podle experta velmi silná a zisky obchodovaných společností mohou trhy táhnout dál nahoru, „ale nečekejte žádné zvyšování PE.“ Jinak řečeno, ceny akcií mohou růst díky tomu, že porostou zisky, ale ne valuace, tedy poměry cen k ziskům. Slimmon si také myslí, že dřívější vyšší pravděpodobnost nižších sazeb neprospívala akciím ve skupině Mag7, tedy velkým technologickým společnostem. Místo toho se investoři obraceli k rizikovější části trhu. Současný posun ve výhledu na pohyb sazeb ale vede k návratu k „managementu rizika“.
Investiční ředitelka Citi Wealth Kate Moore pro Bloomberg řekla, že „trhy z posledního projevu Kevina Warshe dostaly, co potřebovaly.“ Podle ní je v současnosti pravděpodobnost zvýšení sazeb v září 50 na 50, protože se neví, jaká ekonomická data do doby rozhodnutí o sazbách přijdou. Akciové trhy ale podle ní „nejsou tak citlivé na sazby jako celá ekonomika“. Mohutný růst zisků totiž „nebude zastaven sazbami vyššími o 25 bazických bodů.“ Pokud Fed letos oproti dosavadním tvrzením Warshe sazby vůbec nezvýší, bude to podle ředitelky pro důvěryhodnost centrální banky výzva. Nezáleží ale tolik na tom, zda sazby půjdou nahoru v září nebo později.
Tagy: investice, fed, spekulace, akcie, trhy
Reklama
Na tomto místě můžete zahájit diskusi. Zatím nebyl zadán žádný názor. Do diskuse mohou přispívat pouze přihlášení uživatelé (Přihlásit). Pokud nemáte účet, na který byste se mohli přihlásit, registrujte se zde.
Aktuální komentáře
31.08.2026 14:11Morgan Stanley: Pryč od spekulativních akcií 13:02Druhý největší schodek v historii. Vláda navrhla pro příští rok deficit 389 miliard 12:24Týdenní výhled: Warsh zklidnil dluhopisy jen přechodně, trh práce by se měl zlepšit po slabém červenci 11:45Dluhopisy neudržely zisky a kazí tržní sentiment i začátkem nového týdne 11:37Primoco v pololetí meziročně klesl čistý zisk na 29,8 milionu 10:40BYD poprvé vydělává více v zahraničí než doma. Akcie po výsledcích klesají 10:06Ekonomika ČR loni rostla rychleji než průměr EU, výrazně se zvýšil i dluh 9:08ČEZ, a.s.: Skupina ČEZ - Pololetní finanční zpráva 2026 9:08Rozbřesk: Česko roste díky spotřebě a investicím, dražší energie mohou ekonomiku brzdit 8:48Primoco zveřejnilo výsledky, Evropa zahájí poklesem, v Británii je dnes zavřeno 6:02Skutečný důvod, proč evropské akciové trhy nedosáhnou na ty americké 30.08.2026 8:40Víkendář: Nezamýšlené důsledky nových technologií 29.08.2026 8:36Víkendář: Německo čelí velkým výzvám, ale není to poprvé 28.08.2026 22:03Wall Street ustála jestřábí tón Fedu, a tak investoři i nadále věří v sílu amerických akcií 18:07Je plánem čínský globální monopol? 17:03Warsh jestřábím projevem zvýšil sázky na růst sazeb a potěšil trhy 16:50Bloomberg: Venezuela zvažuje odchod z ropného kartelu OPEC, který spoluzaložila 16:06Rohlik.cz Finance II a.s. : Výroční zpráva společnosti 16:04Bernstein: Ve světě je nový zdroj poptávky po kapitálu, probíhat bude postupný úpadek důvěryhodnosti amerických dluhopisů 14:20Od května jsou akcie Alphabetu na ústupu. Skepsi vyvolaly odchody talentů, zpoždění nových modelů či rostoucí náklady
Reklama
Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Kalendář událostí
ČasUdálost 3:30Čína - PMI v průmyslu 14:00DE - Harmonizovaný CPI, y/y
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharma group, has priced a €2.55 billion bond offering, tapping the euro debt market for general corporate purposes.
The notes were issued on Monday by AstraZeneca Finance LLC, a wholly owned US subsidiary, and carry a full and unconditional guarantee from the parent company.
The sale was split across four fixed rate tranches with maturities stretching from 2030 to 2038. The largest is a €750 million tranche maturing on 1 September 2038 with a coupon of 4.169%.
A €700 million tranche maturing in March 2030 pays 3.402%, the cheapest money in the deal. The remaining two tranches comprise €600 million maturing in 2032 at 3.652% and €500 million maturing in 2035 at 3.923%.
The pricing curve reflects the standard pattern of investors demanding higher returns for lending over longer periods.
AstraZeneca described the issuance as consistent with its long-term funding strategy and said proceeds would go towards general corporate purposes rather than any specific project or acquisition.
The company has been an active borrower in recent years as it funds an expanding pipeline and a series of manufacturing commitments, including substantial investment in the United States.
The notes are being issued under the euro medium-term note programme, a standing framework that allows a company to issue debt repeatedly without drafting fresh documentation each time.
They will be listed on the Financial Conduct Authority's Official List and admitted to trading on the London Stock Exchange's main market.
Barclays, Goldman Sachs International and Morgan Stanley (NYSE:MS) acted as joint book-running managers.
For those looking to find strong Finance stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Morgan Stanley (MS - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.
Morgan Stanley is a member of the Finance sector. This group includes 874 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Morgan Stanley is currently sporting a Zacks Rank of #1 (Strong Buy).
Within the past quarter, the Zacks Consensus Estimate for MS' full-year earnings has moved 7.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the latest available data, MS has gained about 20.6% so far this year. At the same time, Finance stocks have gained an average of 7.8%. This means that Morgan Stanley is outperforming the sector as a whole this year.
One other Finance stock that has outperformed the sector so far this year is Andersen (ANDG - Free Report) . The stock is up 92.8% year-to-date.
The consensus estimate for Andersen's current year EPS has increased 2.8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Morgan Stanley belongs to the Financial - Investment Bank industry, a group that includes 22 individual companies and currently sits at #34 in the Zacks Industry Rank. This group has gained an average of 11% so far this year, so MS is performing better in this area.
On the other hand, Andersen belongs to the Financial - Miscellaneous Services industry. This 115-stock industry is currently ranked #101. The industry has moved -6.2% year to date.
Morgan Stanley and Andersen could continue their solid performance, so investors interested in Finance stocks should continue to pay close attention to these stocks.
Morgan Stanley (MS - Free Report) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for Morgan Stanley is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
For Morgan Stanley, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for Morgan StanleyFor the fiscal year ending December 2026, this investment bank is expected to earn $12.79 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Morgan Stanley. Over the past three months, the Zacks Consensus Estimate for the company has increased 7.9%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Morgan Stanley to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Key Takeaways Morgan Stanley's 1H26 revenues rose 21% y/y, while net income jumped 42%.MS benefited from strong IB, trading, wealth management and asset-gathering activity.Morgan Stanley's solid balance sheet, capital returns and fee-based expansion support long-term growth. Morgan Stanley (MS - Free Report) delivered a strong first half of 2026, with net revenues rising 21% year over year to $41.93 billion and net income jumping 42% to $11.15 billion. Earnings per share increased 46% to $6.90, while the return on tangible common equity (ROTCE) improved to 26.8% from 20.6% in the prior-year period.
The Institutional Securities (IS) segment was the major growth driver, supported by robust investment banking (IB) and trading activity. IB revenues rose 47% year over year, aided by stronger M&A advisory and underwriting volumes, while trading revenues increased 36% on higher client activity. The momentum was particularly evident in the second quarter of this year, when IS segment revenues jumped to a record $11 billion.
The Wealth Management (WM) segment also delivered solid growth in the six months ended June 30, 2026, supported by higher asset levels, fee-based inflows, lending activity and client engagement. Second-quarter revenues reached a record $8.9 billion, while the business attracted $148 billion of net new assets. Investment Management (IM) also benefited from higher assets under management (AUM) and positive flows.
Overall, Morgan Stanley’s improving efficiency, strong asset gathering and solid capital position drove its impressive first-half results. Supported by this robust performance, along with improving investor sentiment, resilient U.S. consumer spending and continued heightened market activity, MS shares have gained 22.1% year to date, outperforming the S&P 500 Index’s 11.5% growth and the industry’s 11% rise.
If we compare MS’ price performance with two of its closest peers, JPMorgan (JPM - Free Report) and Goldman Sachs (GS - Free Report) , it appears that MS has outperformed both JPMorgan and Goldman Sachs. So far this year, shares of JPMorgan have gained 10.7% and Goldman Sachs stock has rallied 20.5%.
YTD Price Performance
Image Source: Zacks Investment Research
Given the impressive price performance, investors might be tempted to invest in the MS stock now. But before making any investment decision, investors should assess whether there is further upside left in the stock despite risks from market volatility. In order to understand this, let us dig deep into the company’s fundamental strengths and growth prospects.
Key Positives of Morgan StanleyImproving Diversification: Morgan Stanley has continuously been trying to reduce its reliance on capital markets, which it has been achieving by expanding wealth and asset management. Also, it has been using acquisitions (Eaton Vance, E*Trade Financial, Shareworks and EquityZen) to broaden its mix and have a more balanced revenue stream across market cycles. The wealth and asset management businesses continue to broaden the company’s revenue base and deepen client relationships.
Both businesses’ aggregate contribution to total net revenues jumped to almost 54% in 2025 from 26% in 2010. The WM segment’s total client assets witnessed a five-year (2020-2025) compound annual growth rate (CAGR) of 13%, while the IM segment’s total AUM saw a CAGR of 19.4%.
As of June 30, 2026, total client assets across both segments were $10 trillion, reaching a milestone. This progress reflects strong momentum across Morgan Stanley’s advisor-led, workplace and self-directed platforms, while highlighting its expanding scale in the retirement savings market. The trend is likely to continue in the near term as the operating environment becomes more favorable.
IB Recovery: After the deal slowdown that weighed on results in 2022 and 2023, Morgan Stanley's IB franchise continues to recover as issuance and strategic activity improve. IB fees rose 35% in 2024 and 23% in 2025 as boardroom confidence improved and issuance reopened. As mentioned above, the upward momentum carried into the first half of 2026.
Looking ahead, the company is well-positioned to benefit from a healthier deal environment, supported by a robust and diversified pipeline across regions and sectors. Momentum is expanding beyond the Americas into Asia and EMEA, while active M&A and IPO markets, together with the company’s strong competitive position, should support further growth as the macroeconomic backdrop evolves.
Expanding Global Reach: Morgan Stanley’s alliance with Mitsubishi UFJ Financial Group continues to enhance its competitive position in Japan through combined research, sales and execution and coordinated underwriting. This supports a durable franchise in a key market and helps extend coverage across the region.
Asia revenues were $9.42 billion in 2025, up 23% year over year. The momentum carried into the first six months of 2026, aided by stronger client engagement, favorable market conditions and higher prime brokerage activity in the region.
The company's global platform is increasingly relevant as capital markets activity broadens outside the United States and across Japan, India, China, Korea, Taiwan and Hong Kong. Continued investment in regional leadership and collaboration should support wallet share gains across Asia's capital markets and wealth opportunity set.
Robust Balance Sheet Position: As of June 30, 2026, the company had long-term debt of $383.2 billion, with $34.3 billion expected to mature over the next 12 months. The company’s average liquidity resources were $404.1 billion as of the same date.
Given its solid liquidity position and earnings strength, Morgan Stanley has been engaged in efficient capital distribution activities, through which it enhances shareholder value.
Following the clearance of the 2026 stress test, the company increased its quarterly dividend 15% to $1.15 per share. Before this, the company had hiked its quarterly dividend 8% in 2025. Also, its board of directors has reauthorized a multi-year share repurchase program of up to $20 billion, without an expiration date. Management continues to emphasize disciplined capital allocation, with a preference for organic investment, capital returns and selective bolt-on acquisitions only where strategic and cultural fit are strong.
Analyzing Morgan Stanley’s Valuation & EstimatesOn a valuation basis, shares of Morgan Stanley appear to be trading at a premium relative to the industry. The company’s forward 12-month price/earnings (P/E) ratio of 16.72 is above the industry average of 13.97.
P/E (F12M)
Image Source: Zacks Investment Research
JPMorgan has a P/E (F12M) ratio of 14.28, and Goldman Sachs has a forward 12-month P/E ratio of 14.89. Thus, Morgan Stanley is overvalued compared with its two closest peers as well.
If we look at Morgan Stanley’s earnings estimate revisions, it appears that analysts are optimistic regarding the company’s growth. Over the past 30 days, the Zacks Consensus Estimate for the company’s 2026 and 2027 earnings has been revised upward. The earnings estimate for 2026 of $12.79 indicates a rise of 25.3% from that reported in the previous year. The 2027 estimate of $13.06 suggests year-over-year growth of 2.1%.
Earnings Estimate Revision
Image Source: Zacks Investment Research
How to Approach Morgan Stanley Stock Now?Morgan Stanley’s continued efforts to reduce the dependence on volatile capital markets-driven revenues by strengthening its wealth management and investment management businesses will continue to support growth in the long run because these segments generate more stable, recurring fee income.
Its solid balance sheet and strong capital position provide flexibility to invest in growth initiatives, pursue strategic opportunities and return capital to shareholders.
The company’s premium valuation seems justified by its business transformation and strong earnings stability. With multiple growth levers in place, including expansion in fee-based businesses, disciplined cost management and strategic investments, the company appears well-positioned to sustain financial performance and deliver stable revenue growth over the long term, making it an attractive investment option now.
Currently, Morgan Stanley sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Key Takeaways Morgan Stanley shares gained 45.1% in a year, outperforming industry peers and the S&P 500.MS' Wealth and Investment Management contributed nearly 54% of net revenues in 2025, up from 26% in 2010.Trading business cyclicality and rising expenses could put pressure on Morgan Stanley's results. Shares of Morgan Stanley (MS - Free Report) have jumped 45.1% in the past year, outperforming the industry’s 22.9% growth. In the same time frame, the S&P 500 has rallied 21.3%.
Also, the company’s shares have fared better than its close peers like Goldman Sachs (GS - Free Report) and Citigroup (C - Free Report) . In the past year, Goldman and Citigroup shares have gained 40.7% and 38.6%, respectively.
One-Year Price Performance
Image Source: Zacks Investment Research
Does MS stock have more upside left despite recent strength in price? Let us find out by looking at its fundamentals and growth prospects.
Key Factors Supporting Morgan StanleyBroadening Revenue Base: Morgan Stanley’s strategy of reducing reliance on capital markets remains a key long-term growth driver, supported by the expansion of Wealth and Investment Management divisions and acquisitions, including Eaton Vance, E*Trade Financial, Shareworks and EquityZen. These businesses have diversified revenues and deepened client relationships across advisor-led, self-directed and workplace channels. Wealth and Investment Management segments’ contribution to total net revenues surged to nearly 54% in 2025 from 26% in 2010.
Wealth Management (WM) client assets and Investment Management (IM) assets under management (AUM) recorded five-year compound annual growth rates (CAGRs) of 13% and 19.4%, respectively. As of June 30, 2026, combined client assets reached $10 trillion.
Financial Flexibility and Capital Returns: Morgan Stanley has a solid balance sheet and capital position, providing flexibility to support client activity, invest in technology, and return capital to shareholders. As of June 30, 2026, long-term debt outstanding was $383.16 billion, with $34.3 billion maturing over the next 12 months. Average liquidity resources were $404.1 billion. The company ended the second quarter of 2026 with a standardized CET1 ratio of 14.8%, maintaining a 300-350 basis point capital cushion above requirements. It has accreted $18 billion of CET1 capital over the last 10 quarters, further strengthening its financial flexibility.
Following the clearance of the 2026 stress test, Morgan Stanley increased its quarterly dividend by 15% to $1.15 per share in the third quarter of 2026 and reauthorized a multi-year share repurchase program of up to $20 billion without an expiration date. Management continues to prioritize organic investment, capital returns, and selective bolt-on acquisitions, positioning the company to support growth while maintaining disciplined capital allocation.
Improving Investment Banking Trends: After the deal slowdown in 2022 and 2023, Morgan Stanley’s investment banking (IB) franchise continues to recover as issuance and strategic activity improve. IB fees rose 35% in 2024 and 23% in 2025, with momentum accelerating in the first half of 2026 as fees jumped 47% year over year. A robust and diversified pipeline across regions, improving M&A and IPO activity, and Morgan Stanley’s strong competitive position will likely support further growth as deal-making conditions improve.
Expanding Global Footprint: Morgan Stanley’s alliance with Mitsubishi UFJ Financial Group strengthens its competitive position in Japan through integrated research, sales, execution and underwriting capabilities. Asia revenues rose 23% year over year to $9.42 billion in 2025, with momentum continuing into the first half of 2026, driven by stronger client engagement and prime brokerage activity. Its expanding regional presence across Japan, India, China, Korea, Taiwan and Hong Kong positions the company to capture further capital markets and wealth management opportunities.
Morgan Stanley’s Near-Term HeadwindsTrading Cyclicality: Morgan Stanley’s significant reliance on trading revenues remains a concern given the business’s inherently cyclical nature. Trading activity has rebounded sharply following weakness in 2023, supported by favorable market conditions, elevated volatility, and strong client engagement. However, management has cautioned about potential frothiness in equity markets, particularly AI-related stocks. A normalization in volatility, issuance activity or client risk appetite could make current trading levels difficult to sustain, increasing quarterly revenue variability across market-sensitive businesses.
Rising Expense Base: Morgan Stanley’s expenses have continued to rise despite restructuring and cost-efficiency efforts, increasing at a 7.4% CAGR over the five years ended 2025. As shown in the chart, total expenses have accelerated since 2023 and reached approximately $57.7 billion on a trailing-twelve-month (TTM) basis in 2026. The trend is likely to persist as management increases spending on technology, AI, and data infrastructure. While these investments could support long-term growth, a higher cost base is likely to put pressure on operating leverage if revenue growth moderates.
Expense Trend
Image Source: Zacks Investment Research
Should You Invest in Morgan Stanley Stock Now?The company has surpassed consensus earnings expectations in recent quarters, and the Zacks Consensus Estimate implies continued earnings growth through 2026 and 2027. The consensus estimate for 2026 earnings of $12.79 per share and 2027 earnings of $13.06 implies a rise from $10.21 in 2025. This reinforces the earnings power of its broader franchise and management’s expectations of steady improvement in its core operations.
Earnings Estimates
Image Source: Zacks Investment Research
Morgan Stanley’s diversified revenue base, improving IB activity, strong capital position, and expanding global footprint are expected to support its long-term growth. The continued expansion of wealth and investment management businesses, along with improving deal-making activity, should help the company capitalize on favorable market conditions. Moreover, strong capital levels provide flexibility to invest in growth initiatives while supporting shareholder returns through dividends and share repurchases.
In terms of its valuation, Morgan Stanley stock is currently trading at a trailing 12-month price-to-earnings (P/E) ratio of 17.32, compared with the industry average of 15.78. This indicates that MS is currently trading at a premium to its industry.
P/E TTM
Image Source: Zacks Investment Research
Morgan Stanley trades at a premium to Citigroup, while it is inexpensive compared with Goldman Sachs. At present, Citigroup has a trailing 12-month P/E of 12.83X, while Goldman Sachs trades at a trailing 12-month P/E of 16.04X.
Despite its strong fundamentals and improving earnings outlook, it does not seem a wise idea to invest in MS stock now. The company remains exposed to the cyclical nature of trading and capital markets activity, while persistent expense growth could weigh on operating leverage if revenue growth moderates.
Nevertheless, those who already own MS stock can hold on to it for long-term gains. Currently, Morgan Stanley carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Veteran financial services company Morgan Stanley (MS +3.25%) ended the stock trading week in style. On the back of news that it's approaching the next stage of an ambitious expansion program, investors piled into its stock, pushing it up more than 3% on Friday.
Bigger in Texas Several media outlets reported that Morgan Stanley has selected Dallas as the place where it'll expand its footprint. After market close on Thursday, the New York Post reported that the company will become the anchor tenant of a newly built, 709,000-square-foot skyscraper in the large Texas city.
Image source: Getty Images.
What helped was the city's efforts, according to the report. In June, Dallas' city council passed a set of incentives to coax the finance sector mainstay to put down roots there. These included a conditional $18.5 million grant.
The Post added that Morgan Stanley's Texas decampment, which it added will affect up to 4,800 employees by 2031, is to occur in two phases. The first will see it occupy 255,000 square feet at Fountain Place, a prominent existing Dallas skyscraper. In the second, the company will take up significantly more space in the new building.
Today's Change
(
3.25
%) $
6.75
Current Price
$
214.20
Sign of the (good) times The fact that Morgan Stanley feels compelled to expand its footprint is a clear sign that it's doing quite well, thank you very much.
And there's little reason it shouldn't -- the capital markets it so actively participates in are frothy and, despite concerns over factors like inflation, the American economy continues to grow. Anyone bullish on said economy and markets should consider investing in a powerful player like this company.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Bank of New York Mellon Corp acquired a new stake in shares of Morgan Stanley (NYSE:MS – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 9,759,983 shares of the financial services provider’s stock, valued at approximately $2,040,227,000. Bank of New York Mellon Corp owned 0.62% of Morgan Stanley as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently made changes to their positions in MS. Norges Bank purchased a new position in shares of Morgan Stanley during the fourth quarter valued at approximately $2,736,648,000. Price T Rowe Associates Inc. MD boosted its holdings in Morgan Stanley by 29.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 14,917,776 shares of the financial services provider’s stock valued at $2,648,354,000 after acquiring an additional 3,364,080 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in Morgan Stanley by 142.4% in the fourth quarter. Corient Private Wealth LLC now owns 3,122,060 shares of the financial services provider’s stock valued at $511,723,000 after acquiring an additional 1,833,844 shares in the last quarter. Vanguard Group Inc. increased its position in Morgan Stanley by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 119,718,100 shares of the financial services provider’s stock valued at $21,253,554,000 after purchasing an additional 1,361,940 shares during the period. Finally, Thrivent Financial for Lutherans increased its position in Morgan Stanley by 2,332.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,406,495 shares of the financial services provider’s stock valued at $249,710,000 after purchasing an additional 1,348,683 shares during the period. 84.19% of the stock is owned by hedge funds and other institutional investors.
More Morgan Stanley News Here are the key news stories impacting Morgan Stanley this week:
Positive Sentiment: Morgan Stanley selected Dallas for a major expansion outside New York, signaling long-term investment in Texas, potential operating-cost advantages, and broader access to talent. The move could support growth and geographic diversification, although it may also attract political scrutiny. Morgan Stanley picks Dallas for expansion outside NYC Positive Sentiment: Morgan Stanley’s research highlighted a potential 38-gigawatt power shortfall for AI data centers, identifying industrial and infrastructure companies that could benefit. This reinforces the firm’s advisory and research relevance in the fast-growing AI infrastructure market. Morgan Stanley Says AI Data Centers Face a 38-Gigawatt Power Gap Positive Sentiment: Morgan Stanley reportedly disclosed a 5.6% stake in IonQ, potentially providing upside if the quantum-computing investment appreciates. The position also demonstrates continued access to emerging-technology opportunities, though it is unlikely to materially affect Morgan Stanley’s earnings near term. Morgan Stanley Discloses 5.6% Stake in IonQ Neutral Sentiment: Morgan Stanley raised its gold outlook to above $5,000 per ounce by 2027, which may benefit commodities research, trading, and client activity. However, the forecast itself has limited direct impact on the company’s fundamentals. Morgan Stanley Forecasts Gold to Surpass $5,000 by 2027 Negative Sentiment: A former advisor has accused Morgan Stanley of gender and disability discrimination, inappropriate pressure, confidentiality breaches, and denial of medical leave. The allegations are not adjudicated, but they create potential legal, compliance, and reputational risks. What Is Morgan Stanley Being Accused Of? Negative Sentiment: Scotiabank hired Richard Tory, described as Morgan Stanley’s leading Canadian banker. The departure could raise concerns about talent retention and competitive pressure in Morgan Stanley’s Canadian investment-banking operations. Scotiabank hires Morgan Stanley’s top Canada banker Analyst Upgrades and Downgrades MS has been the subject of several research analyst reports. Rothschild & Co Redburn raised their target price on shares of Morgan Stanley from $183.00 to $195.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. JPMorgan Chase & Co. increased their price target on shares of Morgan Stanley from $187.00 to $195.00 and gave the stock a “neutral” rating in a research note on Thursday, July 16th. Citigroup raised their price objective on shares of Morgan Stanley from $220.00 to $235.00 and gave the stock a “neutral” rating in a report on Friday, July 17th. Oppenheimer cut Morgan Stanley from a “market perform” rating to an “underperform” rating in a research report on Tuesday, June 30th. Finally, UBS Group upped their target price on Morgan Stanley from $255.00 to $260.00 and gave the stock a “buy” rating in a report on Monday, August 3rd. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Morgan Stanley currently has a consensus rating of “Moderate Buy” and a consensus target price of $224.75. Read Our Latest Research Report on MS
Morgan Stanley Stock Performance Morgan Stanley stock opened at $207.58 on Friday. Morgan Stanley has a twelve month low of $142.90 and a twelve month high of $232.25. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 3.65. The company has a market capitalization of $327.41 billion, a P/E ratio of 16.78, a PEG ratio of 1.52 and a beta of 1.22. The stock’s 50 day moving average is $217.16 and its 200 day moving average is $193.98.
Morgan Stanley (NYSE:MS – Get Free Report) last announced its quarterly earnings data on Wednesday, July 15th. The financial services provider reported $3.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.89 by $0.57. Morgan Stanley had a return on equity of 19.31% and a net margin of 15.65%.The business had revenue of $21.35 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the previous year, the business earned $2.13 earnings per share. The firm’s quarterly revenue was up 27.1% compared to the same quarter last year. On average, equities research analysts predict that Morgan Stanley will post 12.79 earnings per share for the current fiscal year.
Morgan Stanley Increases Dividend The company also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 31st were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Friday, July 31st. This is a positive change from Morgan Stanley’s previous quarterly dividend of $1.00. Morgan Stanley’s dividend payout ratio (DPR) is presently 37.19%.
Morgan Stanley declared that its Board of Directors has initiated a stock repurchase program on Wednesday, June 24th that permits the company to repurchase $20.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 5.6% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.
Morgan Stanley Company Profile (Free Report)
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Read More Five stocks we like better than Morgan Stanley 3 Energy Stocks Raising Dividends as the Sector Surges 5 Reasons the S&P 500 Could Keep Rallying Through Year-End Walmart’s Post-Earnings Drop Could Be a Buying Opportunity The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
Morgan Stanley has picked Dallas for a major expansion of its banking empire outside New York City — accelerating Wall Street’s migration to Texas following the election of Mayor Zohran Mamdani, The Post has learned.
The financial giant plans to relocate up to 4,800 jobs to the state by 2031, passing over Alpharetta, Georgia, according to municipal filings reviewed by The Post. The firm will anchor a new $1.3 billion, 709,000-square-foot skyscraper in the fast-growing Texas metropolis known to financiers as “Y’all Street”.
The Wall Street behemoth led by CEO Ted Pick — which began exploring options outside the Big Apple earlier this year following the election of the Big Apple’s socialist mayor — had been weighing the new regional hub against Alpharetta, where it already has 3,000 employees.
Mayor Zohran Kwame Mamdani irritated Wall Street’s financial titans with a video taking a pop at Citadel founder Ken Griffin and his Manhattan pied-a-terre. Mayor Mamdani/X But in June, the Dallas City Council approved incentives including an $18.5 million grant tied to specific hiring benchmarks and a 10-year, 90% property tax abatement — and Morgan Stanley has since plowed ahead with the project, public filings show.
The city’s 15-member Plan Commission quietly rubber-stamped final approval on Aug. 6 for the bank to mount 366.3-square-foot illuminated exterior signs on the Fountain Place tower downtown, following a preliminary sign committee vote in July, filings show. They clearly list the bank as a tenant.
Demolition crews also began clearing a former Gold’s Gym on McKinney Avenue last week to make way for the permanent skyscraper.
“This is the latest in what should be a wake-up call for City Hall,” said Steve Fulop, CEO of the pro-business Partnership for NYC.
“Apollo, Goldman Sachs and JPMorgan have all highlighted Texas as a major hub in just the last few months, with thousands of jobs headed there,” Fulop added. “Texas is playing the long game and rolling out the red carpet for jobs, while New York keeps upgrading the tax calculator. The contrast is pretty clear.“
Morgan Stanley CEO Ted Pick has not commented on the plans, but public records show the bank’s decision has been made. Bloomberg via Getty Images Morgan Stanley and City Hall did not immediately respond to requests for comment. A spokesperson for Dallas Mayor Eric Johnson declined to comment.
Morgan Stanley will execute the move in two phases. The bank will first occupy 255,000 square feet at Fountain Place on 1445 Ross Ave. in downtown Dallas, where contractors will complete a $97 million interior renovation.
Workers will eventually move to the $1.3 billion skyscraper to be located at 2401 McKinney Ave.
Morgan Stanley will first move into a building at Fountain Place before a new $1.3 billion skyscraper is completed. 4kclips – stock.adobe.com The signage filings, submitted by Dallas land attorney Victoria Morris, propose installing illuminated, 366.3-square-foot attached signs featuring three-inch back-lit channel letters reading “Morgan Stanley.”
Construction in Dallas has begun even as state records lag. The Texas Department of Licensing and Regulation shows no new filings for the Fountain Place work or the Uptown tower.
Morgan Stanley has also published a slew of new job openings in the city on the professional networking platform LinkedIn.
Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more.
Thanks for signing up!
The project continues a major shift of Wall Street firms to Texas in search of lower costs and favorable tax rules.
Charlie Jewell, Alpharetta’s economic development director, told The Atlanta Journal-Constitution in June 2026 that local leaders did not engage in a bidding war against Texas for the Morgan Stanley hub.
Demolition crews swooped in last week to raze the old Gold’s Gym. The site is to host Morgan Stanley’s potential regional office in a new 708,000-square-foot tower. Google Maps Just a mile away from the Morgan Stanley site in Dallas, Goldman Sachs is building an 800,000-square-foot urban campus that will host 5,000 staffers.
The migration mounts pressure on Mamdani, who has vowed to heavily tax the rich and rein in corporate real estate.
JPMorgan Chase Chief Executive Jamie Dimon warned in his annual shareholder letter that punitive taxes threaten New York City, noting bluntly that residents and businesses “vote with their feet.”
Citadel founder Ken Griffin has also openly battled the mayor. The dispute erupted in April when Mamdani filmed a viral video outside Griffin’s $239 million Manhattan penthouse to promote a new pied-à-terre tax, a stunt Griffin blasted as “creepy and weird.”
As Space Exploration Technologies Corp. (NASDAQ: SPCX) stock fell by around 6% on August 20, driven by the unlocking of 319 million shares from early investors and employees, Adam Jonas, a Wall Street analyst at Morgan Stanley (NYSE: MS), has predicted a rally towards a new all-time high (ATH) over the next 12 months.
Jonas has maintained a ‘Buy’ rating for SpaceX stock, according to a note sent to clients that Finbold analyzed on Thursday. He reiterated a 12-month price target for SPCX of $300, thereby suggesting a potential 126.89% upside.
The analyst based the bank’s bullish thesis on the assumption that Grok Bot is one step in building an enterprise platform that combines intelligence, real-time data, low-cost and scalable compute into a wide suite of enterprise tools.
Most importantly, Morgan Stanley argued that most investors still value SpaceXAI as a successful neocloud, a specialized cloud provider built primarily for AI and high-performance computing workloads.
Wall Street analysts remain bullish on SpaceX stock As Jonas reaffirmed a bullish proposition for SpaceX, Markus Leistner, an expert at DZ BANK AG, downgraded SPCX to a ‘Sell’ rating earlier on Thursday. As such, 32 analysts surveyed by TipRanks have set an average 12-month price target of $232.35, which suggests a likely 75.73% uptick.
At the time of writing, the highest SPCX stock price forecast for 12 months was $800, while the lowest was at $75, as Finbold reported.
SPCX’s price outlook After a 42% rebound from an all-time low (ATL) of $104.9 earlier this month, SPCX’s price has fallen by over 9% over the past 2 days amid bearish sentiment caused by share dilution. At the time of publication, this company had a market capitalization of about $1.8 trillion.
SPCX’s all-time chart. Source: Finbold Consequently, if SpaceX continues to see growth in its AI amid adoption of Starlink, Jones and Wall Street analysts’ price targets of new ATH for SPCX could be achieved.
Featured image via Shutterstock
Best Crypto Exchange for Intermediate Traders and Investors
Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.
0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.
Copy top-performing traders in real time, automatically.
eToro USA is registered with FINRA for securities trading.
30+ million Users worldwide
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
Join Finbold's newsroom, become a Sales Executive today! Apply now to join Finbold as a crypto/finance news writer!
Shares in Unitree Robotics, the Chinese humanoid robot maker, surged 542% on its Shanghai market debut on Wednesday after raising about 6.1 billion yuan ($905 million) in an initial public offering.
The Hangzhou-based company saw its shares reach 968.1 yuan each, having touched a high of 1,100 yuan during early trading on Shanghai's STAR Market.
DeepSeek, the Chinese artificial intelligence company, backed the listing with an investment of about 140.8 million yuan alongside existing support from Tencent, the Chinese technology group.
Unitree manufactures bipedal humanoid robots capable of walking and manipulating objects with dexterous hands, alongside four-legged machines designed for hazard detection.
Ahead of the listing, the group revealed a new humanoid model named Superman that can jump two metres from a standing start and run at speeds of up to 12.66 metres per second.
The flotation follows last month's debut of CXMT, the memory chipmaker, whose shares climbed 466% on their first day of trading.
Morgan Stanley (NYSE:MS), the investment bank, estimated in June that China's humanoid robot market will expand from $2 billion this year to $15 billion by 2030.
The bank projected domestic shipments will reach 50,000 units this year, nearly double its prior 28,000 estimate, before moving into wider commercial deployments in the second half of the year.
Full-size humanoids are expected to account for 30% of total shipments this year, rising to 70% by 2028.
No Investment Advice
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
NEW YORK--(BUSINESS WIRE)--Dan Simkowitz, Co-President of Morgan Stanley, will speak at the Barclays Global Financial Services Conference on September 15, 2026, at 11:15 a.m. (ET). Both live and on-demand versions of the webcast will be available on www.morganstanley.com in the Investor Relations section. Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offic.
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Morgan Stanley (MS - Free Report) is headquartered in New York, and is in the Finance sector. The stock has seen a price change of 22.54% since the start of the year. Currently paying a dividend of $1.15 per share, the company has a dividend yield of 2.11%. In comparison, the Financial - Investment Bank industry's yield is 1.16%, while the S&P 500's yield is 1.31%.
Looking at dividend growth, the company's current annualized dividend of $4.60 is up 19.5% from last year. Over the last 5 years, Morgan Stanley has increased its dividend 4 times on a year-over-year basis for an average annual increase of 22.85%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Morgan Stanley's current payout ratio is 32%, meaning it paid out 32% of its trailing 12-month EPS as dividend.
Looking at this fiscal year, MS expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $12.79 per share, representing a year-over-year earnings growth rate of 25.27%.
Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. But, not every company offers a quarterly payout.
For instance, it's a rare occurrence when a tech start-up or big growth business offers its shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, MS is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).
Jamie Dimon is one of those big-name CEOs who you seem to read about everywhere. He’s a gifted operator who has had an incredible run as CEO at JPMorgan Chase (NYSE:JPM | JPM Price Prediction).
And yet – when you look at the operational metrics that actually matter (aside from just price returns) and that a bank CEO has actual control over, Ted Pick at Morgan Stanley (NYSE:MS) edges him out. Here’s how:
What a CEO Can Impact At its core, a bank CEO’s job is to allocate resources to the most profitable outcomes – generating a higher net profit margin, boosting return on assets (ROA), and using leverage appropriately to boost return on equity (ROE) while balancing against credit risk.
Metric (TTM, period end 6/30/26) JPMorgan (Dimon) Morgan Stanley (Pick) Return on equity 17.8% 18.0% Return on assets 1.4% 1.4% Net profit margin 34.9% 25.9% Price/book 2.7 3.2 P/E 16 18 Pick (narrowly) wins return on equity; Dimon wins return on assets (very narrowly) and net profit margin (by quite a bit). So you’d think, “case closed,” it’s Dimon by a hair because of the big net profit margin, right?
Well, it turns out that the story is a little more complicated than that…
Digging Deeper Dimon’s figures are flattered by a huge one-time item: Q2 FY26 included a $4.6B net gain tied to a Visa Class C share exchange offer plus $1.0B in equity investment gains – accounting for a total of $1.54 out of the reported quarterly EPS of $7.70. That gain inflates both ROE and ROA.
That’s not to say that Morgan Stanley’s earnings were devoid of gains that also boosted ROE and ROA – there were plenty of things on their end too, just nothing anywhere close to what JP Morgan reported.
The Case for Dimon The case for Dimon can be boiled down to two words: Scale matters.
Q2 FY26 produced revenue of $57.3B with net income of $21.2B, up 41.2%. Commercial and Investment Bank revenue rose 27% to $24.9B, with Equity Markets up 86% to $6.0B and investment banking fees up 30% to $3.3B, the highest since 2021. Assets under management reached $5.1 trillion.
JPMorgan ranks number one in US retail deposits for five consecutive years and number one in global investment banking fees with 9.8% wallet share, across 5,135 branches and 63.7 million active mobile customers, backed by a $50.0B share repurchase program. Dimon’s company-disclosed profitability: “an ROTCE of 23%, excluding gains related to Visa and certain equity investments”.
The Case for Pick Morgan Stanley’s most recent quarter marked a step-change.
Q2 FY26 delivered record revenues of over $21.0B and record EPS of $3.5, with net income of $5.6B, up 57.7%. Equity trading revenue rose 69% to $6.3B, with Asia up 71% to $3.9B. Investment banking rose 58% to $2.4B. Wealth Management added a record $148.0B in net new assets, and total client assets across Wealth and Investment Management reached the $10 trillion milestone. Alternatives and Solutions AUM grew to $852.0B, up 22%.
The expense efficiency ratio improved to 65% in Q1 FY26 from 68% a year earlier. Company-disclosed ROTCE was 26.6% in Q2 FY26, up from 18.2% a year earlier, and 27.1% in Q1 FY26. So as you can see, Morgan Stanley is growing a lot faster…off, admittedly, a much smaller base than JP Morgan.
How Pick (Narrowly) Wins Pick leads on return on equity and company-disclosed ROTCE. The gap widens when stripping out the Visa gain from JP Morgan’s ROE. The same logic applies to Dimon’s ROA edge, which swings to Pick when you strip out those one-time items. Dimon holds net profit margin more clearly, though it is the least comparable metric when comparing a universal bank like Morgan Stanley vs an investment bank like JP Morgan.
Which means, surprisingly enough to me at least, that by these measures, Pick is clearly the better CEO. He doesn’t have the name or the fame or the size of platform that Dimon does, but when it comes down to the actual core work of being a CEO, he’s getting Morgan Stanley to achieve more.
Of course, this is all by a pretty narrow margin, so stay tuned for earnings and let’s see whether Pick can keep this real – but narrow – edge.
Contact [email protected] for any questions or corrections.
NEW YORK--(BUSINESS WIRE)--Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $301.21 per share (equivalent to $0.301206 per Depositary Share)
Key Takeaways Morgan Stanley launched Ethereum and Solana ETPs, expanding its digital-asset product strategy.MSSE and MSOL charge 0.14% and plan to stake part of their holdings for added differentiation.Morgan Stanley now offers Bitcoin, Ethereum and Solana exposure as crypto competition intensifies. Morgan Stanley’s (MS - Free Report) launch of the Morgan Stanley Ethereum Trust (“MSSE”) and Morgan Stanley Solana Trust (“MSOL”) marks a meaningful expansion of its digital-asset product strategy. The two exchange-traded products (ETPs) give investors exposure to ether and SOL through a regulated exchange-traded structure, complementing the Morgan Stanley Bitcoin Trust (“MSBT”), which has already surpassed $381 million in assets under management.
With all three products carrying a 0.14% expense ratio, and MSSE and MSOL intending to stake a portion of their holdings, Morgan Stanley Investment Management is positioning itself to offer a broader and competitively priced range of crypto investment products.
The latest launches build on a strategy that Morgan Stanley has been developing over several years as digital assets have moved closer to mainstream investment portfolios. Morgan Stanley Investment Management introduced its first exchange-traded fund (ETF) in 2023, and has since grown its broader ETF and ETP platform to more than $14 billion in assets across 22 products. The addition of Bitcoin, Ethereum and Solana gives the firm exposure to three of the largest digital assets by market capitalization, while the staking component could make the new products more differentiated than vehicles that simply provide passive price exposure.
Morgan Stanley’s increasing involvement is also important because of the firm’s position within wealth and asset management. The company had previously been more focused on distributing, advising on or providing infrastructure around third-party crypto products. Developing its own ETPs allows Morgan Stanley to bring digital-asset exposure directly into its investment-management and wealth-management ecosystem.
The push into crypto fits with Morgan Stanley’s broader effort to strengthen its wealth and asset management businesses and reduce its dependence on more cyclical capital-markets activities. Acquisitions such as Eaton Vance, E*Trade Financial and Shareworks have expanded the firm’s asset-management capabilities, client reach and recurring revenue base. Crypto ETPs can complement this strategy as digital assets become increasingly incorporated into diversified portfolios. Even relatively modest asset gathering can become economically meaningful over time because ETPs generate recurring fees based on assets under management, while successful products can deepen client relationships across the firm’s broader platform.
MS’ Competitive LandscapeThe competitive backdrop is becoming increasingly important for Morgan Stanley as large asset managers move beyond simply offering spot-crypto exposure. BlackRock (BLK - Free Report) has been pushing the market toward staking-enabled products, with its iShares Staked Ethereum Trust giving investors ether exposure alongside staking rewards. This puts pressure on Morgan Stanley to differentiate MSSE beyond its 0.14% fee, particularly as BlackRock combines its product innovation with the enormous scale of its existing Bitcoin and Ethereum ETP franchise.
Likewise, Invesco (IVZ - Free Report) has expanded its digital-asset lineup through its partnership with Galaxy, including the Invesco Galaxy Solana ETF, which is designed to track Solana’s spot price while incorporating staking rewards, making it particularly comparable with MSOL. Invesco’s broader digital-asset offering also includes Bitcoin and Ethereum products, showing how competition is increasingly moving toward a multi-asset crypto platform rather than individual cryptocurrency funds.
For Morgan Stanley, the competitive dynamic underscores the opportunity and challenges in entering the market now.
Morgan Stanley’s Price Performance, Valuation & EstimatesThe company’s shares have gained 27.2% in the past six months, outperforming the industry’s 16.7% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, MS trades at a 12-month forward price-to-earnings (P/E) of 16.80X, above the industry average of 14.10X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Morgan Stanley’s 2026 earnings suggests a 25.3% rise on a year-over-year basis, while 2027 earnings are expected to grow 2.1%. In the past 30 days, earnings estimates for 2026 and 2027 have moved upward.
Image Source: Zacks Investment Research
Currently, MS carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Betting markets now put a 62% probability on Anthropic listing its shares by the end of October, up 19 percentage points, as the artificial intelligence company edges towards what would be one of the largest flotations in history.
Contracts on Polymarket, a prediction market where users trade on the outcome of future events, imply an 83% chance of a listing by the end of December, though that figure has slipped 7 points.
The nearer-term contracts tell a different story.
Odds on a listing by 15 September have collapsed to 2%, down 33 points, while the 30 September contract has fallen 73 points to 13%.
Together the moves suggest traders have pushed their central expectation back from September into late October, in line with the timetable widely reported since the company filed confidentially for a listing on 1 June.
Anthropic, the developer of the Claude chatbot and a rival to OpenAI, is targeting a Nasdaq debut with Goldman Sachs, JPMorgan and Morgan Stanley (NYSE:MS) leading the offering.
Its most recent private funding round, completed in May, valued the company at about $965 billion.
A listing above $1 trillion would be a first for an artificial intelligence company.
The market has attracted $1.4 million in trading volume, with more than $490,000 of that on the 30 September contract alone.
Related markets price an 85% chance that Anthropic reaches the public markets before OpenAI, which filed its own confidential paperwork a week later, and a 96% chance the company is worth at least $600 billion at the close of its first day.
Only a 3% probability is attached to Anthropic being acquired before 2027, an outcome that would void the listing contracts.
Being financial powerhouses with impressive franchises, both Bank of America BAC and Morgan Stanley MS benefited from stronger capital markets activity, robust trading volumes and improving investment banking (IB) conditions in the first half of 2026. However, their business models differ.
Amidst SpaceX (NASDAQ: SPCX) stock price recovery and the approaching Cursor acquisition, Morgan Stanley’s (NYSE: MS) Adam Jonas reiterated his highly bullish assessment of the company.
Specifically, the Wall Street analyst rated SPCX equity as a ‘Buy,’ while forecasting a 116.23% 12-month rally to $300. Furthermore, Jonas also outlined a SpaceX stock ‘bull case’ at $600 per share, seemingly contingent on Cursor turning from a ‘harness’ and into a ‘frontier’ model.
Additionally, Morgan Stanley explained it sees Cursor’s annualized run rate (ARR) reaching $8 billion by the end of the year and up to $33 billion by 2030. ARR is a somewhat dubious metric as it grants companies significant discretion in choosing a period – usually a month – they will use to calculate the total.
Notably, as bullish as Adam Jonas’ SpaceX stock price prediction is, it is noteworthy that it effectively predicts Elon Musk’s newer public company will boast a market capitalization just short of $4 trillion – between the valuation of Microsoft (NASDAQ: MSFT) and Google (NASDAQ: GOOGL) at the latest close.
While the figure is not impossible, the social media, rocket, internet, and artificial intelligence (AI) company recorded $7.81 billion in earnings in the second quarter (Q2), while the two established technology giants saw $90 billion and $120 billion in the comparable period.
Analysts predict SpaceX stock price in the next 12 months Elsewhere, Morgan Stanley’s latest assessment of SpaceX is only slightly more bullish than the Wall Street average. Indeed, institutional analysts view SPCX stock as a ‘Moderate Buy’ overall, with two ‘Sell,’ five ‘Hold,’ and twenty-four positive recommendations.
Wall Street sets SpaceX stock price target for the next 12 months. Source: TipRanks Furthermore, the average SpaceX share price target for the next 12 months stands at $231.15, meaning the equity is expected to rise 66.61% within the timeframe, per the data Finbold retrieved from TipRanks on August 11, 2026.
SpaceX stock soars 30% from SPCX all-time low Lastly, though SPCX remains 38.51% below the $225.64 all-time high achieved only four days after the initial public offering (IPO), it saw a 32.35% rally from its all-time low of $104.83.
SpaceX stock price one-week chart. Source: Google At its latest closing price of $138.74, SpaceX stock is slightly above the $135 IPO ask, having rallied 18.47% within the last week of trading.
Featured image via Shutterstock
Best Crypto Exchange for Intermediate Traders and Investors
Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.
0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.
Copy top-performing traders in real time, automatically.
eToro USA is registered with FINRA for securities trading.
30+ million Users worldwide
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more.
Join Finbold's newsroom, become a Sales Executive today! Apply now to join Finbold as a crypto/finance news writer!
BFI Infinity Ltd. bought a new position in shares of Morgan Stanley (NYSE:MS – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 20,573 shares of the financial services provider’s stock, valued at approximately $4,301,000. Morgan Stanley comprises about 1.3% of BFI Infinity Ltd.’s holdings, making the stock its 13th biggest position.
Several other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of Morgan Stanley by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 119,718,100 shares of the financial services provider’s stock valued at $21,253,554,000 after acquiring an additional 1,361,940 shares in the last quarter. State Street Corp grew its position in Morgan Stanley by 0.5% during the 4th quarter. State Street Corp now owns 103,854,751 shares of the financial services provider’s stock worth $18,437,334,000 after acquiring an additional 539,544 shares during the last quarter. Geode Capital Management LLC increased its holdings in Morgan Stanley by 2.0% in the 4th quarter. Geode Capital Management LLC now owns 27,070,557 shares of the financial services provider’s stock worth $4,786,350,000 after purchasing an additional 534,708 shares in the last quarter. Fisher Asset Management LLC increased its holdings in Morgan Stanley by 2.1% in the 4th quarter. Fisher Asset Management LLC now owns 25,018,335 shares of the financial services provider’s stock worth $4,441,505,000 after purchasing an additional 524,189 shares in the last quarter. Finally, Bank of America Corp DE raised its position in Morgan Stanley by 0.5% in the first quarter. Bank of America Corp DE now owns 16,326,676 shares of the financial services provider’s stock valued at $2,686,881,000 after purchasing an additional 87,533 shares during the last quarter. 84.19% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In A number of brokerages have recently commented on MS. Royal Bank Of Canada reissued a “sector perform” rating and set a $243.00 price target on shares of Morgan Stanley in a research note on Monday, July 20th. Keefe, Bruyette & Woods raised their price objective on shares of Morgan Stanley from $225.00 to $250.00 and gave the company an “outperform” rating in a report on Thursday, July 16th. Bank of America lifted their target price on shares of Morgan Stanley from $225.00 to $250.00 and gave the stock a “buy” rating in a research report on Tuesday, July 7th. Oppenheimer downgraded shares of Morgan Stanley from a “market perform” rating to an “underperform” rating in a research report on Tuesday, June 30th. Finally, Dbs Bank boosted their target price on shares of Morgan Stanley from $185.00 to $220.00 in a report on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $224.75.
Get Our Latest Research Report on MS
Key Morgan Stanley News Here are the key news stories impacting Morgan Stanley this week:
Positive Sentiment: Morgan Stanley launched a $1.5 trillion innovation and infrastructure initiative designed to support investment in technology, advanced manufacturing, energy and other strategic sectors. The effort could strengthen the firm’s long-term investment-banking, asset-management and advisory opportunities. Morgan Stanley starts $1.5T innovation infrastructure initiative Positive Sentiment: Morgan Stanley upgraded Hewlett Packard Enterprise to Overweight and set a $69 price target, citing improving enterprise-infrastructure growth, earnings potential and cash generation. The call highlights the bank’s ability to generate advisory and trading activity around technology and infrastructure themes. Hewlett Packard Stock Rises After Morgan Stanley Upgrade Neutral Sentiment: Morgan Stanley continues expanding its fixed-income activity through new and recently completed medium-term note offerings carrying coupons of roughly 4.5% to 5.2% and maturities from 2029 through 2036. The issuance supports funding and liquidity but may keep investors focused on borrowing costs and whether the stock’s valuation already reflects strong earnings. Morgan Stanley expands fixed income activity Neutral Sentiment: KBRA assigned preliminary ratings to ten classes of certificates in a $418.1 million Morgan Stanley-sponsored residential mortgage-backed securities transaction. The deal demonstrates continued securitization activity, although its meaningful non-prime mortgage exposure could draw additional attention to credit quality and market-risk management. KBRA assigns preliminary ratings to Morgan Stanley mortgage trust Negative Sentiment: Morgan Stanley-backed renewable developer PNE said potential buyers appear unwilling to meet its market valuation, casting doubt on whether a sale will occur. While the issue is not central to Morgan Stanley’s earnings, it could modestly weigh on sentiment toward the firm’s involvement in the transaction. Morgan Stanley-backed PNE sale prospects unclear Morgan Stanley Stock Down 0.8% Shares of NYSE MS opened at $214.56 on Tuesday. The company’s 50 day moving average price is $216.60 and its 200-day moving average price is $192.08. The company has a debt-to-equity ratio of 3.65, a quick ratio of 0.79 and a current ratio of 0.79. Morgan Stanley has a 52-week low of $141.03 and a 52-week high of $232.25. The company has a market capitalization of $338.42 billion, a P/E ratio of 17.35, a price-to-earnings-growth ratio of 1.53 and a beta of 1.22.
Morgan Stanley (NYSE:MS – Get Free Report) last released its earnings results on Wednesday, July 15th. The financial services provider reported $3.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.89 by $0.57. The business had revenue of $21.35 billion for the quarter, compared to analyst estimates of $19.67 billion. Morgan Stanley had a net margin of 15.65% and a return on equity of 19.31%. Morgan Stanley’s revenue for the quarter was up 27.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.13 earnings per share. Equities analysts forecast that Morgan Stanley will post 12.79 earnings per share for the current year.
Morgan Stanley Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 31st will be paid a $1.15 dividend. The ex-dividend date of this dividend is Friday, July 31st. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.1%. This is a positive change from Morgan Stanley’s previous quarterly dividend of $1.00. Morgan Stanley’s dividend payout ratio (DPR) is presently 37.19%.
Morgan Stanley announced that its board has approved a stock repurchase program on Wednesday, June 24th that allows the company to buyback $20.00 billion in shares. This buyback authorization allows the financial services provider to reacquire up to 5.6% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.
About Morgan Stanley (Free Report)
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Featured Stories Five stocks we like better than Morgan Stanley SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat 3 Dividend Champion Utilities for a Market That Can’t Sit Still These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI First Solar’s Profit Engine Faces a New Policy Test in Washington Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEWeekly Research Analysts’ Ratings Changes for Chipotle Mexican Grill (CMG)
NEXT HEADLINE »Caterpillar Inc. $CAT Stock Position Lifted by Bay Colony Advisory Group Inc d b a Bay Colony Advisors
Firmwide initiative focused on clients building and scaling companies, technologies and infrastructure central to long-term U.S. competitiveness and national security
NEW YORK--(BUSINESS WIRE)--Morgan Stanley today announced the launch of the U.S. Innovation Infrastructure Initiative to finance and enable America’s next era of growth. In recognition of having recently celebrated America’s 250th anniversary, the Firm intends to facilitate approximately $1.5 trillion of capital raising, financing, advisory and related investment activity over the next 10 years. Designed to support clients building and scaling the companies, technologies and infrastructure central to the economic and national security of the United States, the U.S. Innovation Infrastructure Initiative reflects the delivery of the Integrated Firm to our clients, bringing together Morgan Stanley’s advisory, capital markets, wealth management and investment management capabilities to support clients across key stages of growth.
For decades, Morgan Stanley has played a meaningful role in helping American founders, companies, investors, and institutions access capital, evaluate strategic opportunities, and scale over time. Through this work, the Firm supports businesses that drive economic growth, strengthen U.S. competitiveness on the global stage, and advance technology and innovation.
“The United States is entering a period of significant investment and innovation across technology, infrastructure, and strategic industries. America’s 250th anniversary is an opportunity to look ahead and focus on the innovation and infrastructure that will shape the country’s next chapter,” said Dan Simkowitz, Co-President of Morgan Stanley. “Morgan Stanley has long supported clients as they build, finance, and grow important businesses. This initiative brings that impact together through a focused effort to support the companies, technologies, and platforms that are critical to America’s long-term economic strength and competitiveness.”
The U.S. Innovation Infrastructure Initiative will focus on three broad areas:
Innovation Platforms and Strategic Industries
Helping clients build technologies and businesses across areas such as artificial intelligence, advanced computing and software, quantum, semiconductors, data infrastructure, cybersecurity, aerospace and defense technologies, pharmaceuticals, critical minerals, and sectors that are strategic to the reindustrialization of the United States.
Infrastructure for the Innovation Economy
Facilitating the development and financing of the digital, physical, and energy infrastructure, as well as related critical supply chains, required for a more connected, compute-intensive, and energy-demanding economy.
Capital for Builders and Growth Companies
Providing capital markets, advisory, and investment capabilities to founders, entrepreneurs, and established companies as they move from formation and growth to scale, liquidity, public markets access, government funding, and long-term value creation.
The initiative will complement Morgan Stanley’s broader work with founders and growth companies, including private company research coverage, strategic convenings such as the Firm’s Founders Summit, and client engagement across public and private markets.
About Morgan Stanley
Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit www.morganstanley.com.
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to ten classes of mortgage-backed certificates from Morgan Stanley Residential Mortgage Loan Trust 2026-NEW2 (MSRM 2026-NEW2). MSRM 2026-NEW2 is an RMBS transaction sponsored by Morgan Stanley Mortgage Capital Holdings LLC as seller/sponsor and includes a meaningful concentration of collateral that KBRA considers to be “non-prime.” The $418.1 million RMBS transaction is collateralized by a pool of 670 fixed-rate residential mortgages.
CompaniesAug 10 (Reuters) - German renewable project developer PNE (PNEGn.DE), opens new tab on Monday said that interest received so far in its sale process indicated potential buyers were unwilling to match its market valuation, casting doubts on whether a transaction would materialise.
A sale of the company, which counts Morgan Stanley (MS.N), opens new tab as its biggest shareholder, could fetch more than €1 billion ($1.15 billion), Reuters reported in June.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
PNE, which has a market capitalization of €757.61 million, is 50.06% owned by Morgan Stanley, according to LSEG data.
"It is currently uncertain whether a transaction will materialise and what its terms would be," PNE said.
The development comes as Morgan Stanley seeks to cash in on its PNE stake after a previous sale effort ended without success.
Reuters reported last year that Morgan Stanley was working with Goldman Sachs (GS.N), opens new tab to explore a sale. Other shareholders were also prepared to sell, sources have said.
PNE has a 21.7-gigawatt pipeline of wind and solar projects, with more than half in core markets Germany, France and Poland.
Multiple companies have eyed PNE in the past, including Switzerland's Partners Group (PGHN.S), opens new tab and Canada's CPPIB, Reuters reported.
($1 = 0.8663 euros)
Reporting by Mrinmay Dey in Mexico City; Editing by Jonathan Ananda
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has received a US$767,800 purchase order for its FebriDx® rapid diagnostic test from US distribution partner PHASE Scientific, marking further progress in the product’s commercial rollout.
The order will be fulfilled progressively through October 2026, with revenue recognised as products are shipped.
It represents the first purchase order linked to the US$5 million prepayment Lumos received after FebriDx was granted a Clinical Laboratory Improvement Amendments, or CLIA, waiver by the US Food and Drug Administration in March 2026.
Order supports Year 1 commitment The purchase order will contribute toward PHASE Scientific’s minimum Year 1 order commitment under its distribution agreement with Lumos.
Its value will be credited against the US$5 million prepayment, leaving the remaining balance available to support further orders.
Lumos said the timing of the order was significant as US healthcare providers prepare for the upcoming influenza season, when demand for rapid respiratory infection testing is expected to increase.
“We are encouraged by the continued momentum as we advance the commercialisation of FebriDx,” Lumos chief executive officer and managing director Doug Ward said.
“This order comes at an important time as US healthcare providers prepare for the upcoming flu season.
“We look forward to supporting the continued adoption of rapid, point-of-care acute respiratory infection testing across the US market.”
FebriDx targets respiratory infections FebriDx is a rapid point-of-care diagnostic test designed to help healthcare professionals assess acute respiratory infections.
The FDA’s CLIA waiver allows the test to be used in a broader range of healthcare settings in the United States, supporting Lumos’ strategy to expand its commercial footprint in the world’s largest healthcare market.
The PHASE Scientific partnership provides Lumos with an established distribution channel as it works to increase adoption of FebriDx among US healthcare providers.
Next steps Lumos will progressively ship the order through October and continue working with PHASE Scientific to secure further purchase orders against the remaining prepayment balance.
The company will also focus on supporting uptake ahead of the US flu season and building broader adoption of rapid point-of-care respiratory infection testing.
About Lumos Diagnostics Lumos Diagnostics specialises in rapid point-of-care diagnostic technologies designed to help healthcare professionals diagnose and manage medical conditions more accurately.
The company provides customised assay development and manufacturing services, proprietary digital reader platforms and a portfolio of Lumos-branded tests targeting infectious and inflammatory diseases.
The S&P/ASX Small Ordinaries continued its positive run, rising 26.6 points, or 0.8%, to close yesterday at 3,341.2.
The small-cap benchmark has now gained 35.5 points, or 1.07%, over the past five trading days, reflecting steady investor interest across resources, healthcare and emerging technology stocks.
It's a quiet start to the day for new flow as Diggers and Dealers takes centre stage for resource companies. That said, Pantoro Gold is reporting exceptional drilling results, Lumos Diagnostics has secured a major US purchase order and Environmental Clean Technologies and Critica are advancing their respective technology and rare earth strategies. You can read about the following and more throughout the day.
Pantoro confirms high-grade Racetrack continuity Pantoro Gold Ltd (ASX:PNR, OTC:PNTOF, FRA:RKN) has confirmed the continuity of high-grade mineralisation at the Racetrack discovery within its 100%-owned Norseman Gold Project in Western Australia.
Results from the second phase of infill drilling reinforced the potential for Racetrack to become a significant source of high-grade ore and support a material increase in production from the OK Underground Mine.
The standout intercept was 4.94 metres at 349.14 g/t gold from 603.02 metres, including 0.91 metres at 1,737.37 g/t and 0.43 metres at 80.67 g/t.
Pantoro also returned 20.36 metres at 15.55 g/t from 576.29 metres, including 5.94 metres at 43.1 g/t, along with 3.53 metres at 34.44 g/t from 496.72 metres.
Other results included 7.05 metres at 8.82 g/t and 1.85 metres at 11.62 g/t.
The company said the drilling had demonstrated strong mineralisation continuity within Racetrack’s Mainfield, further strengthening its position within Pantoro’s growing pipeline of underground mining opportunities.
Lumos receives US$768,000 FebriDx order Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has received a US$767,800 purchase order from PHASE Scientific for its FebriDx rapid point-of-care diagnostic test.
The order will be delivered progressively through to October 2026, with revenue recognised as products are shipped.
It represents the first purchase order associated with the US$5 million prepayment milestone Lumos received after FebriDx was granted a Clinical Laboratory Improvement Amendments waiver by the US Food and Drug Administration on March 27, 2026.
The regulatory clearance allows the test to be used in a broader range of healthcare settings, including doctors’ offices, clinics and other locations operating under a CLIA Certificate of Waiver.
FebriDx is designed to help healthcare professionals distinguish between bacterial and non-bacterial acute respiratory infections at the point of care, supporting more informed treatment decisions.
ECT expands into advanced materials Environmental Clean Technologies Ltd (ASX:ECT, OTC:ECTHF) has entered a binding agreement to acquire 100% of Xenica Materials Pty Ltd, expanding its exposure to advanced materials produced using Flash Joule Heating technology.
Xenica holds an exclusive licence from William Marsh Rice University to use its proprietary Flash Joule Heating process for the production of MXenes and two-dimensional amorphous carbon.
The acquisition marks a significant step in ECT’s transition into a diversified technology company focused on commercial applications for the rapid electrical heating process.
ECT is already progressing applications for the technology in the remediation of per- and polyfluoroalkyl substances, commonly known as PFAS.
The Xenica acquisition adds exposure to advanced materials manufacturing and industrial processing opportunities.
MXenes are a high-performance class of materials with potential uses in electromagnetic shielding, radar and infrared absorption, advanced sensors, fast-charging batteries, water treatment and next-generation electronics.
However, commercial development has been constrained by reliance on hazardous and expensive acid-based production methods.
ECT believes Flash Joule Heating could replace these processes with a faster and lower-waste electrical alternative, potentially reducing production costs and supporting manufacturing at a larger scale.
Critica advances Jupiter processing optimisation Critica Ltd (ASX:CRI, OTC:VTMLF) (Critica Ltd (ASX:CRI, OTC:VTMLF)) has reported further progress in the hydrometallurgical optimisation program for its Jupiter Rare Earth Project.
The latest work builds on earlier pilot programs that achieved about 81% recovery of magnet rare earth oxides and produced an intermediate concentrate grading about 3% total rare earth oxides.
Previous optimisation also delivered a roughly 14-times upgrade in concentrate grade and improved mass rejection, reducing the amount of material that needs to progress through more expensive downstream processing stages.
Critica has now extended its optimisation work into the hydrometallurgical circuit, with a particular focus on lowering sulphuric acid consumption during the acid-bake stage.
Reducing acid use could improve operating efficiency, lower processing costs and strengthen the broader economics of the Jupiter development pathway.
The company continues to refine the project’s flowsheet as it works to establish a scalable and potentially low-cost processing route for the large-scale rare earth system.
NEW YORK--(BUSINESS WIRE)--E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, which indicates whether clients were net buyers or sellers in each of the 11 core stock market sectors defined by the Global Industry Classification Standard (GICS). These figures, which encompass activity in all US-traded stocks (including OTC) and ADRs, reflect purchases and sales of the individual stocks in each sector, as well as dividend investments and options exercises and assignments.
The three sectors with the most net-buying activity were Materials (+6.85%), Communication Services (+4.30%), and Industrials (+3.06%). The sectors with the most net-selling activity were Financials (-5.47%), Consumer Staples (-3.08%), and Energy (-2.92%).
About E*TRADE from Morgan Stanley and Important Notices
E*TRADE from Morgan Stanley provides financial services to retail customers.
Securities products and advisory services offered by Morgan Stanley Smith Barney LLC, Member SIPC and a Registered Investment Adviser. Commodity futures and options on futures products and services offered by E*TRADE Futures LLC, Member NFA. Stock plan administration solutions and services offered by E*TRADE Financial Corporate Services, Inc., and are a part of Morgan Stanley at Work. Banking products and services are offered by Morgan Stanley Private Bank, National Association, Member FDIC. All entities are separate but affiliated subsidiaries of Morgan Stanley.
More information is available at www.etrade.com.
The material provided by Morgan Stanley Smith Barney LLC (“Morgan Stanley”) or its affiliates) is for educational purposes only and is not an individualized recommendation. This information neither is, nor should be construed as, an offer or a solicitation of an offer to buy, sell, or hold any security, financial product, or instrument discussed herein or to engage in any specific investment strategy by Morgan Stanley.
Past performance does not guarantee future results.
E*TRADE from Morgan Stanley, E*TRADE, and the E*TRADE logo are registered trademarks of Morgan Stanley or its affiliates.
Results land on Tuesday, with the first insider lock-up expiring on Thursday and the shares below their float price
SpaceX Corp (NASDAQ:SPCX) will publish its first set of results as a listed company after the closing bell in New York on Tuesday, two days before the first tranche of insider stock becomes eligible for sale.
Analysts expect second-quarter revenue of about $6.9 billion, a rise of roughly 68% on the same period last year, and a loss of between $0.23 and $0.35 a share.
The company lost $4.9 billion in 2025, and in the first quarter of this year the net loss widened to $4.2 billion from $528 million, on revenue of $4.6 billion.
Nobody expects a profit, which leaves the market focused on the timing and shape of the losses rather than their existence.
The larger event arrives on Thursday, when roughly 911.5 million shares held by early backers and employees become tradeable for the first time.
That is about 20% of restricted insider holdings, worth close to $100 billion at current prices, and comfortably more than the $75 billion raised in the June listing.
Further tranches unlock on a rolling schedule through the autumn, with a 28% release scheduled two days after third-quarter results and the remainder freed by December. Elon Musk's own holding stays locked until June next year.
Morgan Stanley (NYSE:MS) has described the next few days as the most dangerous phase since the flotation, given that the results and the unlock fall within 48 hours of one another.
The bank retains an overweight rating and a $300 price target, on the argument that the market is underestimating the artificial intelligence business.
The shares closed at $108.37 on Friday, against an offer price of $135 and a post-listing peak of $225.64, and short interest stands at around 219 million shares, roughly a third of the free float.
Options markets are pricing a move of 14% to 15% in either direction after the numbers.
Four disclosures matter most.
Starlink profitability is the first, after the satellite broadband arm ended March with 10.3 million subscribers and $3.3 billion of quarterly revenue, around 70% of the group total.
The second is cash generation from Falcon 9 launches, the reliable engine funding everything else.
The third is the scale of spending on computing infrastructure, where estimates put total capital expenditure near $13 billion for the quarter.
The fourth is Starship, where a launch abort on 16 July, followed by a rare Falcon 9 abort four days later, has sharpened questions about execution.
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.
Headquartered in New York, Morgan Stanley (MS - Free Report) is a Finance stock that has seen a price change of 18.53% so far this year. Currently paying a dividend of $1.15 per share, the company has a dividend yield of 2.19%. In comparison, the Financial - Investment Bank industry's yield is 1.15%, while the S&P 500's yield is 1.34%.
Looking at dividend growth, the company's current annualized dividend of $4.60 is up 19.5% from last year. Over the last 5 years, Morgan Stanley has increased its dividend 4 times on a year-over-year basis for an average annual increase of 22.85%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Morgan Stanley's current payout ratio is 32%, meaning it paid out 32% of its trailing 12-month EPS as dividend.
MS is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $12.79 per share, with earnings expected to increase 25.27% from the year ago period.
Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. But, not every company offers a quarterly payout.
For instance, it's a rare occurrence when a tech start-up or big growth business offers its shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. With that in mind, MS presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #2 (Buy).
CNBC Fast Money viewers got a jarring warning on July 27, 2026: the AI infrastructure trade may be built on a debt stack starting to fray. In a segment titled “Digging in on Market Volatility… And SpaceX Hits New All-time Low,” the host argued that hyperscaler credit conditions are quietly deteriorating even as the equity market keeps bidding up buildout beneficiaries.
The specific data point: Meta Platforms (NASDAQ:META | META Price Prediction) is raising $12 billion at 7.5% with weak bond demand, which the host characterized as “just below like freaking junk.” He pointed to Jim Chanos as one of the few voices flagging the mismatch between long-duration debt issuance and the shorter depreciation schedule of the GPUs and servers those bonds are financing. He added that “92% of operating profit is spent on CapEx” across the hyperscaler group, with off-balance-sheet data center obligations going largely undiscussed.
Why the Meta Number Anchors the Warning Meta is the poster child. On its Q1 2026 call, CFO Susan Li lifted the full-year CapEx range to $125 to $145 billion, up from a prior $120 to $135 billion. Q1 CapEx alone hit $19.8 billion, and the company disclosed a $107 billion step up in contractual commitments from multiyear cloud deals, exactly the type of obligation the host flagged. Mark Zuckerberg told analysts “every sign that we are seeing in our own work and across the industry gives us confidence in this investment.” The Q1 2026 8-K lays out the guidance change in full.
The equity has cooled. META is down 8.05% in the past week, 9.88% year to date, and 16.4% over the past year, trading near $593.67. Polymarket traders currently give META just a 51.5% probability of exceeding $40 billion in Q2 CapEx, showing the CapEx number itself is now a debated event.
The Industrials Side of the Trade The host called industrials “the story of AI and margin and efficiency,” flagging XLI into Caterpillar (NYSE:CAT) earnings on August 4, 2026, where consensus sits at $6.25 EPS. CAT’s Power Generation revenue jumped 41% YoY to $2.817 billion in Q1, and the stock is up 53.38% year to date and 103.15% over one year. If hyperscaler credit tightens and orders slow, CAT is the cleanest place cracks would show up first.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Meta didn't make the cut. Grab the names FREE today.
Boeing and Delta as the Non-AI Industrials Case Boeing (NYSE:BA) reported Q2 this morning, posting a core loss of $0.76 per share versus a $0.34 estimate on $24.56 billion in revenue, with 171 commercial deliveries and free cash flow swinging positive to $631 million. Shares are up 3.87% today to $219.68, fitting the host’s framing of Boeing as a laggard coming to life.
Delta Air Lines (NYSE:DAL) was a final trade. Q2 delivered EPS of $1.56 versus $1.50 expected, premium revenue up 17%, and management raised the September-quarter dividend by 15%. Delta trades at a forward P/E of 13 with an average analyst target of $105.52.
The Morgan Stanley Sell-Rallies Call The final wrinkle was a sell-rallies call on Morgan Stanley tied to SpaceX’s performance and the unlikely IPOs of OpenAI and Anthropic. Morgan Stanley (NYSE:MS) posted a blowout Q2 with EPS of $3.46 versus $2.89 expected, equity trading up 69% to $6.30 billion, and total client assets crossing $10 trillion. Shares are up 22.16% year to date. If hyperscaler debt underwriting slows and pre-IPO tech marks compress, MS is the intermediary most exposed on the other side of the trade.
The forward setup: watch CAT’s Power Generation backlog on August 4, watch Meta’s July 29 report for a Q2 CapEx number and any commentary on financing terms, and watch investment-grade tech spreads. If bond demand for hyperscaler issuance stays soft while CapEx guidance keeps climbing, the host’s warning goes from contrarian to consensus quickly.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Meta didn't make the cut. Grab the names FREE today.
NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management (MSIM) today announced the launch of Morgan Stanley Ethereum Trust (NYSE Arca: MSSE) and Morgan Stanley Solana Trust (NYSE Arca: MSOL), two new exchange-traded products (ETPs) that seek to track the performance of ether and SOL, respectively, the native digital assets of the Ethereum and Solana blockchain networks. The launches of MSSE and MSOL reflect the growth of MSIM's ETP suite and the firm's commitment to developing investmen.
Morgan Stanley Investment Management (MSIM) today announced the launch of Morgan Stanley Ethereum Trust (NYSE Arca: MSSE) and Morgan Stanley Solana Trust (NYSE
NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management, through investment funds managed by Morgan Stanley Infrastructure Partners (MSIP), its private infrastructure investment platform, today announced that it has agreed to acquire Epic Energy, an Australian gas pipeline operator. The transaction is expected to close in the second half of 2026, subject to customary regulatory approvals. Epic Energy owns and operates the Moomba to Adelaide Pipeline System, known as MAPS, which connects.
